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ABSTRACT
GLYCINE RECEPTOR EXPRESSION ACROSS IDENTIFIED
RETINAL GANGLION CELL TYPES

Ian Scot Pyle
April 9, 2019

Retinal ganglion cells (RGCs) represent the culmination of all retinal
signaling and their output forms the substrate for vision throughout the rest of the
brain. About 40 different RGC types have been defined by differences in their
visually evoked responses, morphology, and genetic makeup. These responses
arise from interactions between inhibition and excitation throughout the retinal
circuit (Franke et al., 2017; Masland, 2012; Sanes & Masland, 2015; Werblin,
2011). Unlike most other areas of the central nervous system (CNS), the retina
utilizes both GABA and glycine inhibitory neurotransmitters to refine glutamatergic
excitatory signals (Franke & Baden, 2017; Werblin, 2011; C. Zhang, Nobles, &
McCall, 2015). Glycine receptors (GlyRs) are heteromers composed of a single β
subunit and one of four α subunits, with a stoichiometry of 3β:2α (Grudzinska et
al., 2005; Heinze, Harvey, Haverkamp, & Wassle, 2007; Lynch, 2004). All four
GlyRα subunits (α1, α2, α3, or α4) are differentially expressed in the retina and
subunit specific expression has been defined for bipolar, some amacrine cells and
v

RGCs (Haverkamp, Muller, Zeilhofer, Harvey, & Wassle, 2004; Heinze et al.,
2007). The roles for GlyRα subunit specific inhibition are unknown, although
glycinergic input is generally linked to temporal response tuning (Murphy & Rieke,
2006; Nobles, Zhang, Muller, Betz, & McCall, 2012; van Wyk, Wassle, & Taylor,
2009; Wassle et al., 2009; Werblin, 2010). We have surveyed GlyRα subunit
expression in a variety of identified RGC types, using GlyRα knockout mice and
an rAAV-mediated RNAi to knockdown GlyRα subunit specific expression. We find
that the four α RGCs only express GlyRα1. All of the other RGCs we studied
express at least two GlyRα subunits. In some RGCs, the GlyR kinetics are similar,
whereas in others the kinetics differs. We propose that this diversity will contribute
to the richness of retinal inhibitory processing.
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CHAPTER I
INTRODUCTION
1.1 The Visual system
Critical to an organism’s proliferation and survival is its ability to interact with
its environment. More than 500 million years ago, organisms developed
rudimentary photoreceptors to convert energy (light) into information to understand
their surroundings and improve survival outcome. Throughout evolution, the
mammalian visual system became a complex arrangement of neurons and
developed the ability to filter and interpret an ever-changing visual scene. This
process of filtering and interpreting occurs in neural tissue in the eye, called the
retina, and happens rapidly, on the order of tens of milliseconds. In the initial stages
of processing, a diverse array of circuits segregate information into distinct
channels even before transmission to the brain. The parsing of information makes
the visual system more efficient at transmitting signals and interpreting the visual
scene. The retina utilizes complex interactions between inhibitory and excitatory
neurons that are specialized within their particular circuit to create these channels.
Excitatory neurons typically release neurotransmitter onto post-synaptic cells
which bind to excitatory receptors allowing an influx of sodium or potassium ions
to depolarize the post-synaptic cell membrane
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Conversely, inhibitory neurons typically release neurotransmitters, which
bind to inhibitory receptors on post-synaptic cells allowing an influx of chloride ions
into the cell. These ions hyperpolarize the membrane and reduce the probability
of an action potential or help modulate excitatory output. Our understanding of the
interplay of the visual excitatory and inhibitory circuits requires systematic study of
the receptors and their ligands that shape neuronal responses within the retina.
My dissertation will focus on one class of inhibitory receptors that are sensitive to
the neurotransmitter glycine.
1.2 The Retina
The retina is a thin piece of neural tissue (approximately 150 to 400 μm thick
depending on species and the position of the retina measured), located at the back
of the eye, where phototransduction first occurs (Ferguson, Dominguez, Balaiya,
Grover, & Chalam, 2013; Yamada, 1969). The retina is a laminar structure
consisting of five different classes of neurons and two synaptic layers. These cells
classes include the photoreceptors, horizontal cells, bipolar cells, amacrine cells,
and ganglion cells (Figure 1.1). Retinal neuron somas reside in three nuclear
layers: the outer nuclear layer (ONL) contains photoreceptors; the inner nuclear
layer (INL) contains bipolar cells, horizontal cells, and amacrine cells; the ganglion
cell layer (GCL) contains ganglion cells and displaced amacrine cells (Figure1.1).
In between the cellular layers are two synaptic layers called plexiform layers. The
photoreceptors, horizontal cells, and bipolar cells synapse in the outer plexiform
layer (OPL) while the bipolar cells, amacrine cells, and ganglion cells synapse in
the inner plexiform layer (IPL, Figure1.1). These retinal cells synapse together and
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form the parallel circuits, which parse, filter, and process visual input and transmit
interpretable visual signals to the brain such as the ONset and OFFset of light,
direction selectivity, and edge detection.

Figure 1.1 Schematic of the retina. Source: modified figure from (C. Zhang,
2015). The retina contains five unique classes of cells: photoreceptors (PR),
horizontal cells (HC) bipolar cells (BC), amacrine cells (AC) and ganglion cells
(GC). The cell somas are found in the nuclear layers: the outer nuclear layer
(ONL), the inner nuclear layer (INL), and the ganglion cell layer (GCL). Retinal
cell dendrites connect via synapses in the plexiform layers: the outer plexiform
layer (OPL) and the inner plexiform layer (INL). Light passes through the retina
before falling upon the photoreceptor outer segments. Some amacrine cell
somas are found in the GCL and are called displaced amacrine cells (DAC).
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1.3 Photoreceptors
The photoreceptors are comprised of two major classes: rods and cones.
Rods are more sensitive to light at the cost of visual acuity. One rod cell can detect
a single photon, which allows them to function in scotopic, or dim light, conditions
(a luminance of 10−6 to 10−2 cd/m²) (Hecht, Shlaer, & Pirenne, 1941; Tinsley et al.,
2016). Rods transmit lower visual acuity because of the signal convergence of
multiple rods to single bipolar cell targets. Conversely, cone cells are less sensitive
to light, but have greater visual acuity. This increased visual acuity is due to less
signal convergence of cones to their bipolar cell targets; in some cases, only one
cone makes synapses with one bipolar cell target. They primarily function in
photopic or sunlit conditions (a luminance of 1 to 106 cd/m²). With two different
classes of photoreceptors, a mammal, for instance, can interact in an environment
consisting of wider ranges of light diversity. Similarly, most human retinas have
three different types of cone photoreceptors, each being stimulated by a specific
wavelength of light within the visible spectrum. These three cone types allow the
brain to perceive color, again widening the range of environmental interpretation.
Light in the 400-500nm wavelength range is on the lower end of the detectable
range and is coded by cones called short wavelength (S) cones. Medium
wavelength (M) cones detect light in the 500-600nm range, and long (L) cones
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detect light in the 550-650nm wavelength range (Figure 1.2) (Bowmaker &
Dartnall, 1980).

Figure 1.2 Absorbance Spectrum of trivariant color vision from three different
cones. A short (S) cone has an absorbance around 400-450nm wavelength
(blue). A medium (M) cone has an absorbance around 500-575nm wavelength
(green). A long (L) cone has an absorbance around 550-650nm wavelength
(red).
1.4 Photoisomerization
Photopigments called opsins are light-sensitive proteins that reside in the
outer segment discs of photoreceptors and begin the conversion of light energy
into neural information. There are two types of opsins, one for rods called
rhodopsin, and one for cones called cone opsin (Lamb, 2013). While a
photoreceptor is in the dark, (or photons have not activated an opsin),
photoreceptor membrane-bound cGMP-gated cation channels are open, Na2+ and
Ca2+ enter the cell, which causes the photoreceptor cell to depolarize and release
glutamate (Dowling & Ripps, 1973; Suryanarayanan & Slaughter, 2006; Trifonov,
5

1968). This results in a constant depolarizing current in the dark (called the dark
current), and it leads to sustained glutamate release in the absence of photon
activation. However, once an opsin absorbs a photon, which causes
photoisomerization, the membrane-bound cGMP-gated cation channels close,
causing the photoreceptor cell membrane to hyperpolarize (Morgans, 2000). This
reduces glutamate release from the photoreceptor proportionally to the intensity of
light (i.e., the number of photons absorbed in the photoreceptor). The light-evoked
signal is then transmitted through parallel circuits formed by the bipolar cells,
amacrine cells, and ganglion cells and sent to the brain.
1.5 Bipolar Cells
Bipolar cells are the major excitatory interneurons in the retina. The bipolar
cells form synaptic connections with the photoreceptors in the OPL and with the
amacrine cells and ganglion cells in the IPL (Figure 1.1). At least fourteen different
types of bipolar cells are found in the mammalian retina (Euler, Haverkamp,
Schubert, & Baden, 2014; Greene, Kim, Seung, & EyeWirers, 2016). Bipolar cells
fit into two major classes based on their presynaptic photoreceptor partner. Rod
bipolar cells are postsynaptic to rods and cone bipolar cells are postsynaptic to
cones. However, there are instances where cones make synapses on rod bipolar
cells, so a general characterization is not entirely accurate (Pang, Yang, Jacoby,
& Wu, 2018).
Cone bipolar cells can be further divided into two major varieties, OFF and
ON. These two major varieties are the bases for the OFF and ON pathways within
the retina (Ghosh, Bujan, Haverkamp, Feigenspan, & Wassle, 2004). While in the
6

dark, both OFF and ON cone bipolar cells continually receive tonic glutamate from
cone photoreceptors. However, in the dark, the OFF cone bipolar cells are
depolarized and release glutamate in the IPL whereas the ON cone bipolar cells
are hyperpolarized and do not release glutamate. Hence, at the bipolar cell level,
the OFF pathway is more excited in the dark with little inhibition, and the ON
pathway is tonically inhibited. Conversely, when photons activate photoreceptors,
glutamate release is interrupted, so both OFF and ON cone bipolar cells receive
less glutamate. In the light, OFF cone bipolar cells hyperpolarize and stop
releasing glutamate into the IPL, while ON cone bipolar cells depolarize and
release glutamate into the IPL. Therefore, the ON pathway is excited in the
presence of light, while the OFF pathway receives more inhibition.
To maintain the division between the OFF and ON pathways, OFF cone
bipolar cells form synaptic connections with OFF ganglion cells in the upper region
of the IPL (Figure 1.1). This region is called the OFF sublamina of the IPL.
Similarly, the ON cone bipolar cells form synaptic connections with ON ganglion
cells in the lower region of the IPL called the ON sublamina (Figure 1.1). Though
the cone bipolar cells help define these pathways, the rod bipolar cells indirectly
connect to both of these major parallel pathways. In contrast to the cone bipolar
cells, the rod bipolar cells form synaptic connections with bistratified AII amacrine
cells but not retinal ganglion cells (RGCs) (Bloomfield & Dacheux, 2001; Demb &
Singer, 2012) (Figure 1.1). In turn, the AII amacrine cell forms gap junctions with
the ON cone bipolar cells where an excitatory signal can transmit onto the ON
ganglion cells (Demb & Singer, 2012). Additionally, the AII amacrine cell is
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bistratified and also forms inhibitory synaptic connections with the OFF cone
bipolar cells, which in turn are synaptically coupled to OFF ganglion cells (Demb
& Singer, 2012). These three different functional types of bipolar cells are the
foundation for the major parallel pathways in the retina: the ON pathway, the OFF
pathway, and the rod bipolar cell pathway.
1.6 Horizontal Cells
Horizontal cells are one of the major inhibitory neurons in the retina. Located
in the INL, their dendrites innervate the OPL where they form synapses with
photoreceptors. The primary role of horizontal cells is they form a negative
feedback loop to the photoreceptors, utilizing either with a hemichannel-mediated
ephaptic mechanism, and/or Na/HCO3 transporters modulating the local pH of
photoreceptor cell and bipolar cell synapses (Byzov & Shura-Bura, 1986;
Fahrenfort et al., 2009; Kamermans et al., 2001). These cells also release γAminobutyric acid (GABA), but the role of this neurotransmitter is unclear
(Fahrenfort et al., 2009; Kamermans & Werblin, 1992). This feedback loop has
been shown to have an essential role in color constancy and opponency, contrast
enhancement, and forming center-surround receptive fields of cones (Chapot,
Euler, & Schubert, 2017; Kamermans & Werblin, 1992). Horizontal cells are
connected to each other via gap junctions to form an interconnected network
(Kamermans & Werblin, 1992).
1.7 Amacrine Cells
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To date, there are approximately forty known types of amacrine cells
(Akrouh & Kerschensteiner, 2015; Helmstaedter et al., 2013; Masland, 2012). The
primary function of amacrine cells is to release neurotransmitter (GABA or glycine)
into the inhibitory synapses of ganglion cells or bipolar cells or both to integrate
and modulate these cells excitatory output (Park et al., 2018; C. Zhang & McCall,
2012). Some amacrine cells also release less conventional neurotransmitters,
including acetylcholine (S. Lee et al., 2014; Park et al., 2018). The somas of
amacrine cells can occupy either the INL where the bipolar cell somas reside or
the ganglion cell layer where amacrine cells are called displaced amacrine cells
(Figure 1.1). The location of the IPL where amacrine cell dendrites ramify and
whether these dendrites are monostratified, bistratified, or diffuse are the two major
factors that determine the type of circuit with which the amacrine cell is involved.
To date, only narrow-field amacrine cells release glycine and wide-field amacrine
cells release GABA. Co-release of GABA and glycine in a synapse is observed in
regions such as the lateral superior olive, the medial nucleus of the trapezoid body,
and a variety of locations in the spinal cord (Gamlin, Yu, Wong, & Hoon, 2018;
Moore & Trussell, 2017). However, co-release of GABA and glycine has yet to be
observed in the retina. By releasing neurotransmitter into inhibitory synapses of
bipolar cells or RGCs, amacrine cells facilitate the function of four major types of
inhibitory circuits.
1.8 Inhibitory Circuits
The four important inhibitory circuits involving amacrine cells are:
feedforward and feedback, which provide direct inhibition onto their postsynaptic
9

targets and crossover and serial circuits, which provide disinhibition onto their
postsynaptic targets.
An inhibitory feedforward circuit consists of a neuron, which depolarizes and
excites an inhibitory neuron to release neurotransmitter onto the inhibitory
receptors of a third neuron (Figure 1.3A). Succinctly, the excitatory output of the
first neuron causes the second neuron to inhibit the third neuron (Figure 1.3A). An
example of a feedforward circuit is that of a bipolar cell, which excites an amacrine
cell to release inhibitory neurotransmitter onto a ganglion cell (Chen, Hsueh,
Greenberg, & Werblin, 2010).
An inhibitory feedback circuit consists of a neuron, which depolarizes and
excites an inhibitory neuron to release neurotransmitters onto the inhibitory
receptors of the first neuron, thus inhibiting first cell (Figure 1.3B). An example of
a feedback circuit is that of a rod bipolar cell, which releases glutamate (an
excitatory neurotransmitter) onto A17 amacrine cells, which in turn release
inhibitory neurotransmitter (GABA) back onto the rod bipolar cell (Hartveit, 1999).
In addition, a feedback inhibitory circuit can be half of a reciprocal circuit where the
inhibitory component helps enhance the excitatory component of the antagonist
(in relevance to the inhibitory) target (Grimes, Zhang, Graydon, Kachar, &
Diamond, 2010; Nobles et al., 2012).

10

Figure 1.3 Schematic Representations of Different Forms of Inhibition. Source:
modified from (C. Zhang, 2015). A) Feedforward inhibition - excitation of an
amacrine cell initiates inhibition of a bipolar cell or retinal ganglion cell B)
Feedback inhibition - excitation of an amacrine cell starts feedback into the initial
excitatory cell reducing further excitation. C) Crossover inhibition – excitation
11

from one pathway of a bistratified amacrine cell initiates inhibition of a bipolar cell
or retinal ganglion cell of a different pathway D) Serial inhibition – excitation of an
amacrine cell leads to the inhibition of another amacrine cell, which reduces its
inhibitory output resulting in enhanced excitation of the final retinal ganglion cell
target. This type of inhibition is disinhibition.
An inhibitory crossover circuit consists of a neuron, which depolarizes and
excites a bistratified inhibitory neuron to release neurotransmitter onto the
inhibitory receptors of a third neuron, which receives excitatory input from a
different pathway (Figure 1.3C). The bistratified neuron is a crucial component of
crossover inhibition as it facilitates the signal transfer from one major pathway to
another based on dendritic morphology. An example of this circuit is an ON cone
bipolar cell excites an AII amacrine cell, which then inhibits an OFF ganglion cell
(Demb & Singer, 2012).
A serial inhibitory circuit consists of a neuron, which depolarizes and excites
an inhibitory neuron, which releases neurotransmitter onto the inhibitory receptors
of a second inhibitory neuron, which in turn stops releasing neurotransmitter onto
the inhibitory receptors of a fourth cell (Figure 1.3D). The result in an enhancement
of excitatory release to the fourth cell, otherwise known as disinhibition. An
example of a serial inhibitory circuit is a rod bipolar cell stimulates a GABAergic
amacrine cell, which then inhibits a second GABAergic amacrine cell. The second
GABAergic amacrine cell then reduces the inhibition onto a second bipolar cell
(Eggers et al. 2010).
1.9 Retinal Ganglion Cells
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Retinal ganglion cells, the feature detectors of the visual scene, transmit
information about our rich and complex visual environment using spiking signals
to the rest of the brain. The retinal ganglion cell somas reside in the retinal ganglion
cell layer, and their dendrites stratify in the IPL and make synaptic connections
with both bipolar cells and amacrine cells. The forty retinal ganglion cell types
found in the mouse retina are defined by their: morphology, visual response
properties, and genetic profiles (Baden et al., 2016; Bae et al., 2018; Rockhill, Daly,
MacNeil, Brown, & Masland, 2002; Sanes & Masland, 2015). The circuits formed
in the IPL between the excitatory output of the bipolar cells and inhibitory input of
the amacrine cells onto the ganglion cells help complete the retina's interpretation,
filtration, and feature detection of the signal of the visual scene. The axons of the
retinal ganglion cells form the optic nerve and these axons innervate roughly
twenty different areas in the brain; largely the superior colliculus, the lateral
geniculate nucleus, and the suprachiasmatic nucleus of the hypothalamus
(Canteras, Ribeiro-Barbosa, Goto, Cipolla-Neto, & Swanson, 2011; Ellis, Gauvain,
Sivyer, & Murphy, 2016).
1.10 Neurotransmission
Neurons form synapses with each other to orchestrate the transmission of
these different modes of communication. Individual neurons can have as many as
10,000 synaptic connections (Kandel, Schwartz, & Jessell, 2000). Both chemical
and electrical synapses are found in the retina (Kuo, Schwartz, & Rieke, 2016).
Electrical synapses, known as gap junctions are formed by twelve connexins that
bridge between two cells and serve as a low resistance channel, which allows ions
13

to pass between them, effectively transferring charges between cells (Brink,
Cronin, & Ramanan, 1996).
Similarly, chemical synapses form between two cells (a pre-synaptic cell
and a post-synaptic cell). However, chemical synapses form between a
presynaptic bouton and either a small region of a dendrite or the soma of the postsynaptic cell (Figure 1.4). In a chemical synapse, the presynaptic cell releases
neurotransmitters, which are small peptides that act as ligands on the postsynaptic cell receptors. Once a ligand binds to the post-synaptic cell receptor, the
receptor responds by either opening an ionic channel to allow ions to flow across
the membrane (ionotropic) or initiating a signal transduction cascade
(metabotropic). The diversity of transferring information via a chemical synapse is
staggering because of all of the different components at play. A number of different
neurotransmitters have been identified in the retina. They include: glutamate,
acetylcholine, GABA, glycine, and dopamine. Each appears to be stored in
synaptic vesicles, when released bind to their respective excitatory or inhibitory
postsynaptic receptors. The neurotransmitter release properties and the receptor
kinetics differ and can have a major impact on the volume or quanta of
neurotransmitter release and its uptake. Understanding these factors is critical to
our interpretation of how circuits in the retina function and unveiling their roles in
vision.
1.11 Synaptic Release
In preparation for release, neurotransmitters are packaged in synaptic
vesicles in the presynaptic bouton and reside in one of three groups: the readily
14

releasable pool (there might be two of these, one for driven release, and one for
spontaneous release), the reserve, or in the vesicle recycling pathway (Smith et
al., 2012). Vesicle release can be either spontaneous or elicited by an action
potential or graded electrical potential. Synaptic vesicles release their contents into
the synaptic cleft via different mechanisms. A vesicle can fuse with the cell
membrane and release all of its content via exocytosis; a method called full
collapse. Or, vesicles can fuse with the cell membrane and release a portion of
their contents, called partial collapse or fuse-pinch-linger. In a third mechanism,
called kiss-and-run, a vesicle docks with a membrane pore, release a fraction of
its contents, and then undocks from the pore. After a neurotransmitter enters the
synapse, it can bind to a receptor, it can be taken up by a transporter, or if the
concentration is high enough, it can diffuse out of the synapse.
The release of vesicles can be spontaneous, or driven by input to the cell.
Driven release is caused by excitation of the pre-synaptic cell and most or all
vesicles from the readily releasable pool empty their contents into the synapse.
Driven release can occur either synchronously, or asynchronously. Synchronous
release is fast and clearance of the synapses happens rapidly (Eggers &
Lukasiewicz,

2006b).

Contrarily,

Asynchronous

release

is

slow,

and

neurotransmitter concentration remains high in the synapse, long enough to
“spillover” and out of the synapse (Eggers & Lukasiewicz, 2006b; Keros & Hablitz,
2005; Smith et al., 2012). Spillover often results in neurotransmitter binding to
extrasynaptic receptors or receptors in a different synapse. (Eggers & Lukasiewicz,
2006b; Keros & Hablitz, 2005).
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The spontaneous release of the vesicles is stochastic, likely dependent on
the extracellular calcium concentration of the presynaptic cell, and the
spontaneously released vesicles come from a vesicle pool other than the readily
releasable pool (Smith et al., 2012). Moreover, spontaneous release can involve a
single vesicle release (univesicular) or multivesicular release. Univesicular release
involves only one vesicle releasing its contents at a time; the spontaneous postsynaptic currents that result from univesicular release are called “minis.” Mini’s also
demonstrate the release of a single quantum of vesicle contents (Eggers &
Lukasiewicz, 2006b; Moore-Dotson, Klein, Mazade, & Eggers, 2015). Multivesicular release comprises of multiple vesicles releasing their contents into the
synapse simultaneously. The simultaneous release of multiple vesicle contents
results in larger post-synaptic current amplitude. Spontaneous release can be
measured by recording the change in postsynaptic current via whole cell patch
clamping. To isolate inhibitory inputs, the cell’s membrane potential is held at the
reversal potential for cations (C. Zhang, Rompani, Roska, & McCall, 2014). These
currents are then analyzed to answer questions related to spontaneous release.
1.12 Inhibitory Receptors in the Retina
In

the

central

nervous

system,

inhibition

shapes

excitatory

neurotransmission (Eggers, McCall, & Lukasiewicz, 2007). GABA receptors
predominately mediate inhibition in the brain, whereas; glycine receptors
predominately mediate inhibition in the spinal cord (Haverkamp, 1995; Haverkamp
et al., 2004; Legendre, 2001). In addition to the spinal cord, glycine receptors are
found in the brain stem, cerebellum, hippocampus, calyx of Held, and in the retina
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(Hruskova et al., 2012; Manzke et al., 2010). Interestingly, both GABA and glycine
receptors are expressed throughout the retina (Haverkamp et al., 2004; Nobles et
al., 2012).
In the retina, GABAARs expressed on retinal ganglion cells detect GABA
release from wide field ACs, which mediate spatial properties of center and
receptive field surround (Manookin, Beaudoin, Ernst, Flagel, & Demb, 2008;
O'Brien, Richardson, & Berson, 2003). The GABAergic amacrine cells innervate
either the ON or the OFF sublamina of the IPL to form serial inhibitory circuits or
reciprocal inhibitory circuits (Veruki, Gill, & Hartveit, 2007). Small dendritic field
bistratified or diffuse amacrine cells release glycine at their synapses with bipolar
cells or RGCs within the IPL (Haverkamp, 1995; Haverkamp et al., 2004; Veruki et
al., 2007; Weiss et al., 2008). Frequently, these amacrine cells cross over the ON
and OFF sublamina of the IPL to facilitate crossover inhibition (MacNeil & Masland,
1998; Nobles et al., 2012). My dissertation focuses on the expression of glycine
receptors in the retinal ganglion cells.
1.13 Glycine Receptors
Glycine receptors are heteropentameric ligand-gated chloride ion channels.
Figure 1.4A illustrates a typical glycine receptor containing one type of GlyRβ
subunit and one of four different types of GlyRα-subunits (Fig1.5B) (GlyRα1,
GlyRα2, GlyRα3, and GlyRα4; (Cascio, 2006; Dutertre, Drwal, Laube, & Betz,
2012; Lynch, 2004, 2009; Wassle et al., 2009). The most predominant glycine
receptors are heteromeric and are composed of three GlyRβ subunits and two
GlyRα subunits (Figure 1.4C). Heteromeric expression of two different GlyRα
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subunits within one GlyR has only been observed only in heterologous systems
(e.g., Xenopus oocytes) (Figure 1.4C); (Kuhse, Laube, Magalei, & Betz, 1993).
Homomeric GlyRs, made of five of the same GlyRα subunits, are rare but have
been found in situ, for instance at the calyx of held (Figure 1.4C) (Hruskova et al.,
2012). To date, all four heteromeric GlyRs (GlyRα1, GlyRα2, GlyRα3, and GlyRα4)
have been found in the mouse retina (Heinze et al., 2007; Veruki et al., 2007;
Wassle et al., 2009; Y. Zhang, Dixon, Keramidas, & Lynch, 2015).

Figure 1.4 Schematics of glycine receptors. Illustration sourced from the
Australian Society for Biophysics. A) Illustration of the transmembrane
heteropentameric chloride ion channel glycine made of three β subunits and two
of the same α subunits. B) Illustration of a single α subunit of a glycine receptor.
Each α subunit is made from four major transmembrane domains and both the N
and C terminuses are on the extracellular portion of the subunit. The M2 domain
of the α and β subunits face the interior of the channel pore. C) Illustration of a
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heteromeric GlyRα1, heteromeric GlyRα3, and homomeric GlyRα2 glycine
receptors. Notice the lack of β subunit in the homomeric GlyRα2 glycine receptor.
1.14 Glycine Receptor Kinetics
Receptor channel current kinetics are either derived from the subunit
structure of the receptor, which can be influenced by auxiliary protein modulation
such as phosphorylation. The receptor kinetics are measurable based on the
current fluctuations they produce when opening and closing. These fluctuations
are called postsynaptic currents. A current is evoked when a ligand binds to the
postsynaptic receptor and opens the channel. In the case of glycine receptor
channels, chloride ions flow into the cell until: a) the ligand dissociates from the
receptor, which closes the channel or b) the channel desensitizes and closes after
a certain timecourse. Current research suggests glycine receptors do not
desensitize (Singer & Berger, 1999). While the glycine receptor channel is open,
the inward flow of chloride ions hyperpolarizes the postsynaptic cell, which leads
to inhibition. The timing of these glycinergic currents appears to depend primarily
on the receptor alpha subunit, as the binding characteristics are similar for each
subunit specific alpha receptor class. In addition, ligand concentration at the
receptor, temperature, receptor expression density at the synapse, and
phosphorylation of the glycine receptors also can modify the basic alpha receptor
based current kinetics (Beato, 2008; Lynch, 2004; Maksay, 1996). Typical glycine
concentration in the synaptic cleft is ~3mM and glycine is cleared by glycine
transporters (GlyTs) in ~0.7 ms (Beato, 2008). Furthermore, glycine receptors are
insensitive to rapid desensitization, which may help contribute to their ability to
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match high frequency of excitatory inputs (Awatramani, Turecek, & Trussell, 2004;
Singer & Berger, 1999).
The different GlyRs are distinguishable from their spontaneous inhibitory
post-synaptic currents (sIPSCs) (Figure 1.5). The sIPSCs that result from different
GlyRα subunits have different kinetics, which include their rise time and decay time
(τdecay). Rise time is defined as the time it takes for the amplitude of the sIPSC to
rise from 10% to 90% of its peak (Figure 1.5A). The τdecay is defined as the time it
takes for the current to fall from peak to 37% (D37) of the peak (Figure 1.5B). A
shared characteristic across the four heteromeric glycine alpha receptors is a rapid
rise time between approximately 2 and 7 ms (Gill, Veruki, & Hartveit, 2006; Russell
& Werblin, 2010). Similarly, the four heteromeric glycine alpha receptors exhibit
similar binding affinities, although these estimates vary across systems (Lynch,
2004). The four heteromeric GlyR alpha subunit mediated sIPSCs have distinct

τdecay times. (Table 1.1) (Majumdar, Heinze, Haverkamp, Ivanova, & Wassle, 2007;
Majumdar, Weiss, & Wassle, 2009). Although estimates of the decays of the
various alpha subunits have been published, the currents were recorded at room
temperature, which is known to slow down current kinetics (Majumdar, Heinze,
Haverkamp, Ivanova, & Wassle, 2007; Majumdar, Weiss, & Wassle, 2009). My
experiments were conducted at 36° C and I found the τdecay is faster for each
subunit compared to the previously published data (Table 1.1). Under these
conditions, GlyRα1 has the fastest τdecay with an average of ~3ms; GlyRα3 has a
slightly slower τdecay with an average of ~7ms, and GlyRα2 and GlyRα4 both have
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much slower τdecay each with an average of ~20ms. These different decay kinetics
suggest that the different types of GlyRs have specific independent functions as
inhibitory receptors.
Throughout the CNS, glycine receptors are associated with mechanisms
that shaping temporal excitatory responses. They tune rhythmic motor output in
the spinal cord, sustained and transient OFF responses in RGCs, and they match
temporal suppression of high frequency excitatory responses in the mammalian
calyx of Held (Awatramani et al., 2004; Bracci, Ballerini, & Nistri, 1996; Caldwell,
Daw, & Wyatt, 1978; Nobles et al., 2012). The need for a variety of glycine receptor
alpha subunit specific kinetics is demonstrated in inhibitory circuits found in both
bushy and T stellate cells of the ventral cochlear nucleus (VCN). In the bushy cells
of the VCN, kinetically slow GlyRs tonically adjust voltage-gated ion channels to
modulate EPSC driven spike timing that ultimately increases the spike threshold
and improves spike precision (Xie & Manis, 2013). Conversely, kinetically fast
GlyRs expressed on the T stellate cells of the VCN mediate inhibition that
coincides with fast EPSC input that does not interfere with spike threshold but
inhibits slow NMDA currents (Xie & Manis, 2013). These two examples illustrate
the need for precise temporal inhibition of varying kinetics, which can modulate
specific excitatory signal in consonance or in interpolation.
Table 1.1 (τdecay of GlyRα subtypes)
τdecay (ms) at 36°C

GlyRα Subunit
α1
α2
α3
α4

2.96±0.3 ms
26.59±0.5 ms
9.23±0.2 ms
21.85±0.4 ms
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Figure 1.5 Representative examples of an IPSC waveform demonstrating both
rise time and τdecay. The example of an IPSC rise time measurement is the time it
takes for the amplitude to rise from 10% to 90% of the peak (in green). An
example of an IPSC τdecay time measurement is the time it takes for amplitude to
descend from the peak to 37% of the peak (in red).
1.15 Differential Expression of GlyRα Subunits in the IPL of the retina
In the retina, the GlyRβ subunit is expressed ubiquitously, whereas each of
the GlyRα subunits is expressed differentially across the IPL (Figure 1.6). GlyRα1
expression is found in both the OFF and ON sublamina of the IPL, with higher
expression in the OFF sublamina of the IPL (Figure 1.6A). The expression is likely
higher in the OFF sublamina because the AII amacrine cell (the most abundantly
expressed amacrine cell) makes inhibitory synapses with OFF cone bipolar cells
and OFF ganglion cells, while it makes gap junctions with ON ganglion cells (Demb
& Singer, 2012). The GlyRα2 expression density throughout the IPL is the most
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abundant of the GlyRs. (Figure 1.6B). The GlyRα3 expression is in four distinct
bands across the IPL, which appear to be separated by the three calbindin bands
(Figure 1.6C). Finally, GlyRα4 expression is concentrated in a distinct band in the
upper ON sublamina and, with sparse expression throughout the rest of the IPL
(Figure 1.6D). The combination of different decay kinetics and differential
expression further implies functional differences among the four GlyR isoforms
(Wassle et al., 2009).

Figure 1.6 Representative confocal images of transverse wild type sections
stained for glycine receptor subunit expression (green) across the IPL. A) GlyRα1
puncta expression is distributed throughout the IPL, but more abundant in the
OFF sublamina. B) GlyRα2 puncta expression is substantial throughout the IPL.
C) GlyRα3 puncta expression is in a laminar pattern throughout the IPL. D)
GlyRα4 expression is limited to a distinct band in the upper ON sublamina, yet
some sparse puncta are seen E) Calbindin (red) Representative confocal image
of transverse INL, Inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion
cell layer. Scale bar, 20 μm. (Image from Nobles et al. (2012), J Neuroscience).

In the inner retina, evaluation of the decay kinetics of glycinergic sIPSCs as
well as immunohistochemistry show that OFF cone and rod BCs express GlyRα1
and that ON cone BCs have no glycinergic inputs (Figure 1.1) (Eggers et al., 2007;
Ivanova, Muller, & Wassle, 2006; Majumdar et al., 2007; Wassle et al., 2009).
Assays of a small subset of morphologically identified ACs indicate differential
expression of GlyRs. Narrow-field ACs express GlyRα2, AII ACs express either
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GlyRα3 and/or GlyRα1 (Gill et al., 2006), and starburst ACs (SACs) express
GlyRα4 and may also express GlyRα2 (Haverkamp et al., 2004; Heinze et al.,
2007; Majumdar et al., 2009; Weiss et al., 2008). In addition, the large soma OFFα
RGC express only GlyRα1 (C. Zhang et al., 2014).
Zhang et al. determined that GlyRα1 input on OFFα RGCs helps modulate
the spontaneous excitatory activity to improve the signal to noise ratio and slightly
hyperpolarizes the cell reducing the spiking probability. Furthermore, GlyRα1 input
in OFFα RGCs helps diminish the rebound excitation caused by the transient
suppression of spiking from ON cone bipolar cells during an OFFset stimulus.
Finally, OFFα RGCs express GlyRα1, which receives crossover inhibition
mediated by glycinergic input from the AII amacrine cell during the onset of light.
Does GlyRα1 have a similar role in other GlyRα1 only expressing RGCs or does
its role differ based on the retinal ganglion cell response properties? Collectively
the RGCs with the largest soma diameters only make up about 8% of all RGCs
expressed in the retina (Sanes & Masland, 2015). Which GlyRs are expressed on
the other ~92% of RGCs is unknown and a significant gap in our knowledge.
Furthermore, these cells may express or co-express any of the four different GlyRα
subunits, and these GlyRs may serve different functions. Using established
techniques, we intend to further unveil the unique GlyR expression of specific types
of retinal ganglion cells.
II. SPECIFIC AIMS
Ramón Y Cajal caricaturized elegant and accurate descriptions of retinal
cells. These images and descriptions inspired many to investigate and decipher
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retinal circuitry and the components that facilitate vision. As the previous review
portrays, we know a great deal about the components and function of the retina.
Retinal biologists continue to discover new cells types, genes, transcription factors,
and circuit pathways at a rapid pace. These newly discovered components of the
retina generate new questions and new gaps in our knowledge. For instance, we
have limited understanding of the subunit-specific GlyR expression in the RGCs,
even though we know there is differential expression of all four different GlyRs
throughout the IPL. Furthermore, subunit-specific glycine receptor function is
unknown and they could play different roles depending on the specific RGC visual
response properties. I set out to identify subunit specific GlyR expression in RGCs
using the following aims.
Aim 1 – Identify Glycinergic Expression on a Subset of Retinal Ganglion Cells
Aim 1 of my dissertation is to identify and characterize the glycinergic
expression across nine different RGC types and one displaced amacrine cell.
Ideally, these ten cell types will collectively include all four glycine receptor
subunits. First I will examine three of the four RGCs with the largest somas, the
ONα, ONT, and OFFδ. Together with the previously examined OFFα RGC, these
RGCs complete a homolog set for major visual response properties- ON/OFF and
transient/sustained. The glycine alpha subunit receptor expression of OFFα RGCs
was identified by Zhang et al., and I will verify this finding using a similar assay (C.
Zhang et al., 2014). I will examine glycine receptor expression in the following other
retinal cell types: ON starburst amacrine cells, bistratified ON/OFF direction
selective (ooDS) RGCs, local edge detectors, high definition RGCs, ultra-high
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definition RGCs, asymmetric F-mini RGCs, and JAMB RGCs. Together, these
cells represent about 60% of all RGC types in the mouse retina and characterize
a variety of distinctive morphology and visual response properties.
Aim 2 - Examine the GlyRα Expression of ooDS RGCs using an rAAVGlra4shRNA
Aim 2 of my dissertation is to investigate the glycine receptor expression of
the ooDS RGC. In the absence of GlyRα2 or GlyRα4, glycinergic sIPSC frequency
does not change, although in the double knockout of GlyRα2 and GlyRα4 the
glycinergic sIPSC frequency is almost completely reduced. Thus, a mechanism
must exist that compensates for the loss of one of the glycine receptors in these
RGCs. We will use an adeno-associated virus (rAAV) delivered short hair pin RNA
(shRNA) to knockdown GlyRα4 expression and determine if the glycinergic sIPSC
frequency decreases. This experiment will indicate if a compensatory mechanism
exists in the amacrine cells (which will not lose GlyRα4) and if the compensation
mechanism is present after full development of the synapse. Compensation
mechanisms could include: an increase in glycine release from the presynaptic
amacrine cells, due to an overall loss of glycinergic input in the upstream circuit or
an increase in GlyR expression or trafficking to the postsynaptic site as a
consequence of differential expression of these glycine alpha subunits during
development.
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CHAPTER II
EXPERIMENTAL MATERIALS AND METHODS
2.1 Animals
All experiments were carried out in accordance with the Association for
Research in Vision and Ophthalmology “Statement for the Use of Animals in
Ophthalmic and Visual Research” and with the approval of the Institutional Animal
Care and Use Committee of the University of Louisville. The mice were housed in
a facility at the University of Louisville Health Sciences Center and received daily
care from the veterinary staff. The mice were kept on a 12-hour light 12-hour dark
schedule and fed chow ad libitum.
I used three different single GlyR knockout (KO) mice (Table 2.1) as well as
crosses between these knockout mice to form double GlyR knockout mice. I used
reporter mouse lines that express fluorescent proteins in specific retinal ganglion
cells (RGCs) for experiments to establish the baseline glycinergic responses and
create hypotheses for which glycine receptors are expressed onto those specific
ganglion cells (Table 2.1). These reporters were used alone for wild type (WT)
controls and were also bred to single and double KOs as indicated in Table 2.1.
To test for loss of glycine receptor function on specific ganglion cells, we used the
single or double GlyR knockout lines crossed to the reporter lines (Table 2.1).
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Table 2.1. List of Animal Lines Used for Experiments

Strain name

Source/Jackson lab
stock#

Glra2-/-

Young-Pearse et al., 2006;
007065

Glra3-/-

Harvey et al., 2004; 007065

Cells targeted

Chapter
III,
III

All RGCs

Glra4-/-

Created in our lab

Glra2-/-/3-/-

Glra2-/- X Glra3-/-

III

Glra2-/-/4-/-

Glra2-/- X Glra4-/-

III, IV

Thy1Stp-EYFP

Gift of J. Sanes;(Buffelli et al.,
2003); 005630

PVCre

PvalbCre X Thy1Stp-EYFP ;
(Farrow et al., 2013)

Glra2-/-/PVCre

Glra2-/- X PVCre

Glra3-/-/PVCre

Glra3-/- X PVCre

Glra4-/ /PVCre

Glra4-/- X PVCre

Glra2-/-/3-/-/PVCre

Glra2-/-/3-/- X PVCre

III

Glra2-/-/4-/-/PVCre

Glra2-/-/4-/- X PVCre

III, IV

TRHR-GFP

Gift of A. Huberman

III, IV

Glra4-/-/TRHR

Glra4-/- X TRHR

Glra2-/-/4-/-/TRHR

Glra2-/-/4-/- X TRHR

ChAT-cre/Ai9

Gift of W. Guido; ChAT-cre
(006410) X Ai9(007905)

Glra4-/-/ChAT-cre/Ai9

Glra4-/- X ChAT-cre/Ai9

Glra2-/-/4-/-/ChAT-cre/Ai9

Glra2-/-/4-/- X ChAT-cre/Ai9

TYWY3

Gift of J. Sanes;

Glra3-/-/W3

Cre expressing cells

III, IV

III
III

ooDS RGCs, ONα,
ONT, OFFα, OFFδ,
PV4, LED, OFFT,
F-mini

ooDS RGCs

III, IV
III
III, IV

III, IV
III, IV
III

ON SACs

III
III
III

Glra3-/- X W3

LED, HD1, HD2,
UHD

TYWY7

Gift of J. Sanes;

ONT, OFFα, OFFδ

III

HoxD10-GFP

Gift of D. Berson; (MMRRC id
32065)

Glra2-/-/HoxD10

Glra2-/- X HoxD10

JAMBCreER/STP

Gift of J. Sanes;

Glra4-/-/JAMBCreER/STP

Glra4-/-

Glra2-/-/4-/-/JAMBCreER/STP

Glra2-/-/4-/- X JAMBCreER/STP

X

III

III
HoxD10

III
III

JAMBCreER/STP
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JAMB

III
III

2.2 Viral Vector Construction and Packaging
To circumvent the problem of using a global knockout to eliminate all of one
GlyRα subunit and affecting GlyRα subunit expression in bipolar cells and
amacrine cells, we developed an rAAV delivered method to target just RGCs and
eliminate their expression of specific GlyRαs using shRNA. Our lab successfully
demonstrated this method in Zhang et al. 2014 where an rAAV virus was packaged
with an shRNA that when expressed, knocked down the expression of GlyRα1 only
in RGCs; the methods used to create this virus were also published in Zhang et al.
(Fig 2.2A) (Zhang et al., 2014). We used the same plasmid but switched out the
shRNA target of Glra1 for Glra4.
We tested a series of four different Glra4 shRNA constructs using cell
culture, transfection, and immunoblotting. Briefly, Human Embryonic Kidney
(HEK293T) cells were cultured in high-glucose DMEM supplemented with 10%
fetal bovine serum, 2 mM L-glutamine, 50 IU/ml penicillin, and 50 µg/ml
streptomycin. Cells were seeded on 6-well culture plates one day prior to
transfection and transfected with a GlyRα4 expression plasmid tagged with FLAG
and Myc, with or without shRNA plasmids, using jetPrime reagent (Polyplustransfection, New York, NY) according to the manufacturer’s instructions. Thirtysix to sixty hours after transfection, cells were harvested in NP-40 lysis buffer
(50mM Tris, 150mM NaCl, 2mM EDTA, and 1% Nonidet P40, pH 8.0,
supplemented with protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO)) and
disrupted by rotating for 45 min at 4°C followed by sonication. Cell debris was
removed by centrifugation at 17,000 X g for 15 min at 4°C, the supernatant was
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collected, and protein quantified using the Bradford reagent (Bio-Rad, Hercules,
CA). Twenty-five µg of total protein lysates were loaded per lane and analyzed on
4–12% NuPAGE gels (Invitrogen, Thermo Fisher Scientific, Waltham, MA),
transferred to PVDF membranes and blocked with Odyssey Blocking Buffer (LICOR, Lincoln, NE). Membranes were incubated with primary antibodies (rabbit
anti-Flag, 1:2000 and mouse anti-β-actin; 1:25000) diluted in Odyssey Blocking
Buffer and washed four times with TBS containing 0.1% tween-20 (TBST). After
incubating with IRDye800 CW and IRDye680 CW-conjugated secondary
antibodies diluted in Odyssey Blocking Buffer, membranes were washed four times
with TBST. Protein bands were visualized by scanning the membranes in an
Odyssey Infrared Imaging System (LI-COR, Lincoln, NE) using both 700 and 800
nm channels. β-actin was used as a loading control (Figure. 2.1A-B).
We chose the 29mer shRNA-D to insert into the in the pGFP-V-RS vector,
Origene, Rockville, MD) where the plasmid included: flanking Inverted terminal
repeats, elongation factor-1 promoter, a tdTomato gene with a nuclear localization
sequence, woodchuck hepatitis post-transcriptional regulatory element, a
polyadenylation site to protect the mRNA from degradation, the H1 promoter and
the Glra4KD-shRNA cassette (Figure 2.1C). The plasmids were packaged into the
recombinant 2/7 rAAV vector serotype using a standard triple-plasmid protocol by
co-transfection of HEK293T cells to create the rAAV-Glra4KD-shRNA (Grieger,
Soltys, & Samulski, 2016; McClements & MacLaren, 2013; Reid & Lipinski, 2018)
(Fig2.2B).
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Figure 2.1. Glra4KD-D chosen among four different shRNA candidates
A) Immunoblots of HEK lysates transfected with Flag-tagged Glrα4 expression in
each lane with: lane 1, Glrα4 expression alone, lane 2, mock, lanes 3-6 Glra4KD
shRNA candidates A-D, and lane 7, shRNA negative. Β-actin expression was
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used as a control. B) Quantified and normalized immunoblot data, note Glrα4
expression alone was normalized to 100%. All Glra4KD candidates were
successful, but shRNA-D was chosen due to the demonstration of the least Glrα4
expression. C) Plasmid map (image from SnapGene Viewer, GSL Biotech,
Chicago, IL) for pAAV-Ef1a-NLStdtomato-H1-Glra4-shRNA-D, which was used to
create the rAAV-Glra4KD-shRNA
2.3 rAAV injection into Major Optic Nerve Targets of the Brain.
Anesthesia was induced by an intramuscular (IM), intraperitoneal (IP)
injection of a mixture of ketamine (70mg/kg) (VetaKet, Akorn, Lake Forest, IL) and
xylazine (12mg/kg) (AnaSed, LLOYD, Shenandoah, IA) and to maintain
anesthesia, an additional booster (50% concentration of the original solution) was
administered subcutaneously and the dosage and time administered was noted.
The mouse vibrissae and scalp were shaved. The mouse was placed on a
temperature feedback-controlled heating pad to maintain body temperature. The
mouse head was secured in a stereotaxic frame with ear bars and a bite bar.
Wetting eye drops (1.3% polyvinyl alcohol, OCuSOFT, Rosenberg, TX) were
applied to both eyes and were covered with small plastic lenses to maintain
lubrication. A ground wire was inserted subcutaneously above right shoulder. A
midline incision was made to expose the skull, and a craniotomy was performed
at 0.5 mm anterior and 0.5 mm temporally left of Lambda over the superior
colliculus (SC), or at 2.5 mm posterior and 2.5 mm temporally to the left of Bregma
over the dorsal lateral geniculate nucleus (dLGN). The craniotomies were 2mm by
2mm in size. To locate the SC or the dLGN a borosilicate glass pipette (inner
diameter of 40-50 μm) was filled with ~10 µl of Ringer's solution and positioned
over the craniotomy. The pipette was lowered from the surface of the brain to
between 1000 µm and 1200 µm for the SC and 2700 µm and 3000 µm for the
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dLGN. The pipette contained an electrode, which was connected to an FHC Xcell3+ microelectrode amplifier (FHC, Bowdoin, ME) and a Grass Instruments AM-10
audio monitor (Grass Instruments, Warwick, RI). The contralateral eye was
stimulated with a full field light source, and audible spiking responses from the
amplifier and monitor were used to verify the tip of the electrode had penetrated
the SC or dLGN. The depth of the pipette tip was recorded and the exploratory
pipette was carefully removed. A second pipette with an inner diameter ~20 µm
was filled with 3.0 µl of the virus solution and positioned over the same coordinates
as the exploratory pipette. The virus filled pipette was lowered to the recorded
depth and 2.5 μl of the virus was injected into the SC or dLGN. The pipette was
slowly removed from the injection site after 10 minutes to ensure the virus solution
did not flow out of the injection site.
The mouse was then removed from the stereotaxic and placed on a heating
pad where its scalp was sutured using a tissue adhesive (VetBond, 3M, St. Paul,
MN). The animal was given a 100 μl dose of Carprofen (1.25 mg/ml) (Putney,
Portland, ME) subcutaneously above the shoulder blades. Four weeks post rAAV
injection, RGCs with tdTomato positive nuclei were targeted in the retina for patch
experiments.
2.4 Tissue Dissection and Preparation
Under dim red light and at room temperature, dark-adapted animals were
euthanized, eyes enucleated, and the lens and cornea were removed leaving the
eyecup. The retina was carefully removed from the eyecup and incubated in a
solution of Ringers, collagenase (241 units/ml) and hyaluronidase (34.5nM per ml)
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(Worthington Biochemicals, Lakewood, NJ) for 10 minutes to break down the
vitreous attached to the retina. Remaining vitreous was carefully removed and the
enzyme solution was washed 3 times with fresh oxygenated Ringers. The retinas
were quartered, each quarter was placed RGC side up onto a coverslip, and a
harp was placed on top of the retina to hold it in place. The entire apparatus was
placed into the microscope bath perfused with oxygenated Ringer’s solution and
kept at 36°C using a preheated Ringer’s source and a feedback temperature
controlled microscope bath.
2.5 Electrophysiology Recording of Retinal Ganglion Cells
RGCs were observed using a Nikon Eclipse E600FN microscope with a
Nikon Fluor 60x water immersion objective with Hoffman Modulation Contrast
(Nikon, Tokyo, Japan). When targeting RGC somas in the PVCre or TRHR reporter
line retinas, fluorescent protein-expressing somas were observed using a Lumen
Dynamics X-Cite Series 120Q lamp. In virus-infected retinas, RGC somas double
labeled with GFP (green) and tdTomato positive (red) nuclei were targeted. Glass
electrodes (5-7 MΩ of resistance) were made using Kwik-Fil borosilicate glass
capillaries (1B150F-4, World Precision Instruments, Sarasota, FL), which were
pulled using a P-97 Flaming/Brown micropipette puller (Sutter Instruments,
Novato, CA). The electrodes were filled with an intracellular solution that consisted
of: (in mM) 12.5 CsCl, 107 CsOH, 107 D-Gluconic Acid, 10 Na+ HEPES, 10
BAPTA, 5 QX-314(Br), 4 ATP, and 0.5 GTP, 5 lidocaine N-ethyl bromide (QX314Br), 2 Lucifer Yellow CH Lithium Salt, 7.5 neurobiotin tracer (pH 7.2 adjusted with
CsOH).
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Cell recordings were obtained using an Axon MultiClamp 700B patch clamp
amplifier (Molecular Devices, San Jose, CA) and the signals were digitized at 10
kHz using an Axon Digidata 1322A (Molecular Devices, San Jose, CA). Signal
input and output were monitored and recorded using Axon MultiClamp 700B and
Clampex 10.2 software (Molecular Devices, San Jose, CA). RGCs were held at
the reverse cation potential (VHold) of +15 mV (0mV after accounting for the liquid
junction potential) to determine the GlyRα subunit expression. At this holding
potential, and under three different pharmacological conditions, I recorded
spontaneous inhibitory postsynaptic currents (sIPSCs).
2.6 Pharmacological Manipulations of sIPSCs
To isolate specific RGC activity, the cell could be recorded in three different
bath conditions: 1) A Control bath solution, which consists of Ringer’s solution (in
mM) 110 NaCl, 2.5 KCl, 1 CaCl2, 1.6 MgCl2, 10 D-glucose and 22 NaHCO3,
bubbled with 5% CO2/95% O2, pH 7.4) was used to perfuse the tissue. sIPSCs
recorded in the control condition include both GABARs and GlyR activity. 2)
Ringer’s solution containing the GABAR blockers: picrotoxin [20μM] – GABAAR
antagonist (PTX) & TPMPA [50μM] – GABACR antagonist). The sIPSCs recorded
in this condition are isolated spontaneous glycinergic sIPSCs. 3) Ringer’s solution
containing the two GABAR blockers and the GlyR blocker strychnine (STRYCH)
[10μM] – GlyR antagonist. sIPSCs recorded in this condition would come from an
inhibitory receptor excluding GABARs or GlyRs.
2.7 Light Stimulation
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During patch clamp recordings, I measured light-evoked inhibitory and
excitatory postsynaptic currents and inhibitory postsynaptic currents using a fullfield light stimulus presented with a light emitted diode (LED) positioned above the
patched cell. The LED emitted a photopic stimulating luminance of 3.7E 03 R* for
all experiments. The light stimuli protocol consisted of a 30ms light presentation
followed by a 2 second interstimulus interval followed by a 2 seconds light stimulus.
A protocol consisted of 5 total presentations with a period of 15.25 seconds in
between repeats. The responses to the five presentations were averaged and
analyzed using Clampfit software (Molecular Devices, San Jose, CA). Statistical
analyses were performed using GraphPad Prism (GraphPad, San Diego, CA).
2.8 Immunohistochemistry
After patch clamp recording, the pieces of retina with recorded and filled
RGCs (Lucifer Yellow and neurobiotin) were fixed in 4% paraformaldehyde for 12
minutes, washed three times with 0.01 M phosphate buffer saline (PBS), and
placed into a 24-well plate. Retina pieces were incubated in blocking solution
consisting of PBX (0.5% Triton-X 100 in PBS) and 10% normal serum (donkey or
goat) for 60 minutes. Each retina piece was then reacted with a combination of
primary antibodies to stain for the either GlyRα1, GlyRα2, GlyRα3, or GlyRα4 or a
combination of two GlyRαXs, and Lucifer yellow overnight at 4°C (Table 2.2). In
the case where the Lucifer yellow antibody was not compatible, streptavidin was
used to stain for the filled cell, but was added with the secondary antibodies. The
single GlyR antibody or combination of GlyR antibodies were selected based on
our observed τdecay estimates that we matched with the τdecay estimates from the
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literature (Table 3.2) (Gill et al., 2006; Majumdar et al., 2007; Majumdar et al.,
2009; Veruki et al., 2007; Wassle et al., 2009) The primary antibodies were washed
off by a series of washes with PBX. Afterwards, a combination of secondary
antibodies and Hoechst stain (or also streptavidin) in normal serum was added to
label the primary antibodies and it was left on the tissue overnight at 4°C (Table
3.2). The Hoechst stain was used to label the DNA in the somas and distinguish
between the retina nuclear and plexiform layers. The tissue was then washed with
PBS and mounted onto a slide and covered using VECTASHIELD (Vector Labs,
Burlingame, CA) clear mounting medium and a coverslip.

Table 2.2. List of Antibodies Used for Immunohistochemistry Experiments
Ab host / type

Target

CONC.

Manufacturer

Catalog No.

mouse monoclonal 1°

GlyRα1

1:500

Synaptic systems

Cat # 146 111

goat polyclonal 1°

GlyRα2

1:50

Santa Cruz Biotech.

Cat #SC17279

rabbit polyclonal 1°

GlyRα3

1:100

Chemicon

Cat# AB5472

rabbit polyclonal 1°

GlyRα4

1:100

Chemicon

Cat# AB9696

Rabbit polyclonal 1°

Lucifer yellow

1:1000

ThermoFisher

Cat# A-5750

donkey / Alexa 555 2°

anti-mouse

1:200

Life Technologies

Cat# A31570

donkey / Cy3 2°

anti-goat

1:200

JAX ImmunoResearch

Cat# 115165003

goat / Cy3 2°

anti-mouse

1:200

JAX ImmunoResearch

Cat# 111165003

goat / Cy3 2°

anti-rabbit

1:200

JAX ImmunoResearch

Cat# 705165003

DAPI (Vectashield)

DNA cong.

1.5 μg/ml

Vector Laboratories

Cat# H-1500

Hoescht

DNA cong.

1:1000

Life technologies

Cat# H3570

The recorded and filled RGCs in the mounted tissue were imaged using an
Olympus FV1000 confocal microscope. Whole RGC images were acquired using
a 40x water immersion (NA 1.15) objective, and dendrites and puncta expression
were acquired using a 60x oil immersion objective (NA 1.4). Images were recorded
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with Fluoview software (Olympus, Tokyo, Japan). The depths of the RGC’s
dendritic ramifications were measured relative to the top of the GCL and the bottom
of the INL. Combining a RGC’s dendritic ramification depth, dendrite arbor
diameter, and light response help identify and verify specific RGC types.
2.9 Electrophysiology Recording Analysis
The Mini Analysis program (Synaptosoft, Decatur, GA) was used to identify
sIPSCs and determine their decay time constant “τ.” In raw recordings, an sIPSC
was defined as a waveform whose peak exceeded twice the root mean squared
(RMS) of the noise in the system (the noise in our system was usually between 1.5
and 5.0 pA). Single sIPSCs were detected from a template that had and a fast
monotonic rise time to a single peak, and an exponential decay (Figure 1.5). The
10-90% rise time, and frequency of these sIPSCs were measured and their decay
kinetics were estimated from a least-square fit of 10-90% of the decay phase, using
a single exponential decay function. The goodness of fit was determined by
comparing to a least-square fit of 10-90% of the decay phase a single to a double
exponential function. All of the sIPSCs included in further analyses met these
criterion and were used to calculate the average decay tau ( τdecay), again using a
single exponential fitting to a least-square fit of 10-90% of the decay phase (Figure
1.5). Only sIPSCs that represented isolated events were used to calculate the

τdecay of glycinergic sIPSCs. The τdecay of the average glycinergic sIPSC from each
cell was also fit to both a single exponential and a double exponential. The R
squared values for the single and double exponentials were always similar,
indicating the single exponential was a sufficient fit to the average sIPSC. The
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sIPSC τdecay data was plotted in cumulative frequency distributions, frequency
distributions, and average sIPSC τdecay per cell. These τdecay distributions were
compared across cells classes in WT, KO, and injected animals using the
Kolmogorov–Smirnov test. The number of sIPSCs measured in 100sec was used
to determine the frequency of sIPSCs/sec for each cell. The mean frequencies for
each cell type were compared across other cell classes in WT, KO, and injected
animals using a one-way ANOVA with a Bonferroni post-hoc test.
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CHAPTER III
EXPRESSION OF DISTINCT GLYCINE RECEPTOR SUBUNITS IS FOUND
ACROSS IDENTIFIED RETINAL GANGLION CELL TYPES
INTRODUCTION
The retina is a laminar structure with each layer populated by specific
classes of neurons. The vertical connections among these cells across layers form
a variety of parallel circuits that encode the visual scene into electrical signals. The
retinal ganglion cells (RGCs) represent the culmination of this signaling and their
output forms the substrate for vision throughout the rest of the brain. There are
about 40 different RGCs and they are defined by their genetic makeup,
morphology, and visual responses (Baden et al., 2016; Bae et al., 2018; Masland,
2001; Sanes & Masland, 2015). The differences in the responses across the
different types of RGCs arise from direct, feedforward inhibition as well as many
forms of inhibition that modulate their excitatory input (Franke et al., 2017;
Masland, 2012; Sanes & Masland, 2015; Werblin, 2011). Unlike most other areas
of the CNS, the retina utilizes both GABA and glycine neurotransmitters and
receptors in inhibitory processing (Franke & Baden, 2017; Werblin, 2011; C. Zhang
et al., 2015).
Where GABA receptors are heteropentamers composed of a combination
of five of 17 different subunits (α, β, γ, δ, and ρ subunits) glycine receptors
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(GlyRs) have a simpler composition (Bormann, 2000; Yang, 2004). Retinal GlyRs
are heteropentamers with three of the same β subunits and two of the same α
subunits, in a stoichiometry of 3β:2α. (Betz & Laube, 2006; Grudzinska et al., 2005;
Nobles et al., 2012). There are four different α subunits (α1, α2, α3, and α4) that
underlie four different GlyRs isoforms: GlyRα1, GlyRα2, GlyRα3, and GlyRα4
(Dutertre et al., 2012; Wassle et al., 2009). The rise time of the glycinergic sIPSCs
across the four GlyRs is similar; the 10% to 90% of peak rise time ranges between
1 and 3ms (Wassle et al., 2009; Weiss et al., 2008). In contrast, the decay kinetics
(τdecay) of GlyR sIPSCs mediated by the four isoforms differs. At room temperature
their decays have been measured as: fast GlyRα1 (2-4 ms), medium GlyRα3
(~10ms) to slow GlyRα2 and GlyRα4 (20-40 ms) (Lynch, 2004; Majumdar et al.,
2007; Majumdar et al., 2009).
In the mature spinal cord, brain stem, and sub-cortical regions, GlyRα1 is
the primary glycinergic isoform with GlyRα3 expressed to a lesser extent (Lynch,
2004, 2009). In contrast, all four α subunit isoforms are expressed in the retina.
The pattern of expression of each of the GlyRs differs across the inner plexiform
layer (IPL) (Nobles et al., 2012; Wassle et al., 2009). Both the expression of these
subunits and their pattern of expression is conserved across a broad range of
species such as zebrafish to non-human primates (David-Watine et al., 1999;
Harvey et al., 2000; Leacock et al., 2018; Matzenbach et al., 1994). GlyRα1
expression is found throughout the IPL, with its densest expression in the OFF
sublamina, where it is localized on the OFF cone bipolar cells (Haverkamp et al.,
2004; Nobles et al., 2012). GlyRα2 expression is dense and uniform throughout
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the IPL (Haverkamp et al., 2004; Nobles et al., 2012). GlyRα3 is expressed in three
distinct lamina across the IPL and it has been suggested this pattern indicates
GlyRα3 is involved in different glycinergic circuits (Haverkamp et al., 2003;
Haverkamp et al., 2004; Nobles et al., 2012). GlyRα4 is expressed in a thin band
along the top of the ON sublamina of the IPL and co-localizes with the ON Choline
Acetyltransferase (ChAT) band associated with ON starburst amacrine cells
(SACs) (Heinze et al., 2007; Nobles et al., 2012).
Subunit specific GlyR expression has been identified in several retinal cell
classes. OFF cone and rod bipolar cells express GlyRα1 (Eggers et al., 2007;
Haverkamp, 1995; Sassoe-Pognetto, Wassle, & Grunert, 1994). Some subsets of
the narrow-field cells, such as AC type 5/6 and type 7 express GlyRα2 (Majumdar
et al., 2009; Weiss et al., 2008). But this is not the rule, AII amacrine cells, which
also are narrow-field, express GlyRα3 and possibly GlyRα1 (Demb & Singer, 2012;
Gill et al., 2006; Majumdar et al., 2009; Weiss et al., 2008), and the GABAergic
wide-field SACs express GlyRα4 (Haverkamp et al., 2004; Majumdar et al., 2007;
Weiss et al., 2008). Among the αRGCs, GlyRα1 is expressed by OFFα RGCs
(Majumdar et al., 2007; Sun, Li, & He, 2002; Veruki et al., 2007; C. Zhang et al.,
2014). This then suggest that GlyRα subunit specific inhibition is diverse across
retinal cell types and because of their different decay kinetics could represent
additional diversity of inhibitory processing that is likely to influence visual
processing.
To begin to expand our view of the role glycine subunit specific inhibition,
we characterized the rise and decay kinetics of GlyRα mediated synaptic events,
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e.g., glycinergic spontaneous inhibitory postsynaptic potentials (sIPSCs) in eight
identified wild type (WT) RGC types. In addition, we examined GlyRα subunit
specific expression, using immunohistochemistry. Based on these characteristics,
we formulated hypotheses about the composition of GlyRα subunits in each of
these eight RGCs types. We tested our ideas by altering GlyRα subunit specific
expression, using global GlyRα2, 3 or 4 knockout (KO) mice and retrogradely
transported rAAV shRNA to knockdown expression of GlyRα subunits within
mature RGCs.
We found significant GlyRα subunit diversity across identified RGCs. Like
OFFα RGCs, the other three α RGCs (those with the largest somas/dendritic
arbors) also expressed GlyRα1 (Farrow et al., 2013; Krieger, Qiao, Rousso,
Sanes, & Meister, 2017; Majumdar et al., 2007; Sanes & Masland, 2015). In
contrast, the other six RGC types that we studied (e.g., local edge detectors, high
definition, ultra-high definition, F-mini OFF transient, Junction adhesion molecule
“B” (J-RGCs) (Jacoby & Schwartz, 2017; Liu & Sanes, 2017; Rivlin-Etzion et al.,
2011; Rousso et al., 2016; Sanes & Masland, 2015) as well as the ON SACs
expressed two different GlyRαs. In some, the decay kinetics were similar (both fast
or both slow) and in other RGCs, the decay kinetics differed (one fast and one
slow). Thus, GlyR diversity is likely to be the basis for enhanced subunit specific
inhibition in the modulation of RGC visual responses.
MATERIALS AND METHODS
Animals
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We used cell type specific mouse reporter lines to target RGCs for these
analyses (Table 1). All experiments followed the ARVO Statement for the Use of
Animals in Ophthalmic and Visual Research and were approved by the Institutional
Animal Care and Use Committee (IACUC) of the University of Louisville. We
induced GFP expression in JAM-B-CreER mice by daily intraperitoneal injections
of 100 μl of 20 mg/ml tamoxifen solution (100mg of tamoxifen (Sigma-Aldrich, St.
Louis, MO) in 5 ml corn oil) for three days.

Table 3.1. List of Animal Lines and their Labeled Cells Used for Experiments
Mouse line

KO crosses

cell types labeled

References

B6Pvalb tm1(cre)Arbr/J/Thy1 S T P E Y F P (PvCre/Thy1STP)

Glra2-/-, Glra3-/-,
Glra4-/-, Glra2-//Glra3-/-, Glra2-/Glra4-/-

ONα, ONTrans, OFFα,
OFFδ, ooDS RGC,

Hippenmeyer et al. 2005,
Zhang et al. 2014 Farrow et
al., 2013

OFFα, OFFδ

(I. J. Kim, Zhang, Meister, &
Sanes, 2010)
(Jacoby & Schwartz, 2017; I.
J. Kim, Zhang, Meister, &
Sanes, 2010; Y. Zhang, Kim,
Sanes, & Meister, 2012
ChAT-cre
(Jackson
Laboratory) (Rossi et al.,
2011) Ai9 (Allen Institute)
(Liu & Sanes, 2017)

TYW7
TYW3 (W3)

Glra3-/-

LED, HD1, HD2, UHD

ChAT-cre/Ai9

Glra2-/-, Glra4-/-,
Glra2-/-/Glra4-/-

Displaced ON starburst
amacrine cell

JAM-B-CreER

Glra2-/-,
/Glra4-/-

Intrinsically asymmetric
orientation
selective
RGCs

Glra2-/-

Viral Vector Construction and Production
Methods to create the rAAV-Glra1-shRNA have been published (Zhang et
al 2014), and are briefly described here. Serotype 2/7 recombinant rAAVs were
made using a standard triple-plasmid protocol by a transient co-transfection of an
vector plasmid, rAAV helper plasmid (harboring Rep/Cap), and Ad-helper plasmid
(pGHTI-adeno1) into HEK293T cells. The rAAV vector plasmid was a pGFP-V-RS
vector, Origene, Rockville, MD), which included: flanking Inverted terminal repeats,
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elongation factor-1 promoter, a tdTomato gene with a nuclear localization
sequence, woodchuck hepatitis post-transcriptional regulatory element, a
polyadenylation site to protect the mRNA from degradation, the H1 promoter and
the 21mer Glra1-shRNA cassette (Figure 1). The transfected cells were cultured
in high-glucose DMEM supplemented with 10% fetal bovine serum, 2 mM Lglutamine, 50 IU/ml penicillin, and 50 µg/ml streptomycin. The packaged rAAVs
were concentrated and purified from the total cell lysate using iodixanol gradient
centrifugation and collected in the 40% iodixanol band. Genome copy number
titration was evaluated using RT-PCR (Applied Biosystems, TaqMan reagents).
The titer of the rAAV-Glra1-shRNA was 3.5 X 1012 vg/ml.
Viral Injections in the Dorsal Lateral Geniculate Nucleus or Superior Colliculus
Methods to inject virus into the dLGN have been published (C. Zhang et al.,
2014) and also are described briefly. In addition, we also injected virus into the
superior colliculus (SC), using a similar approach. Mice were anesthetized, placed
on a feedback controlled heating pad to maintain body temperature at ~ 36°C and
their heads were secured in a stereotaxic with ear cups and a bite bar. Eyes were
lubricated with 1.3% polyvinyl alcohol and the corneas protected from dehydration
with plastic contact lenses. All injections used stereotaxic coordinates (Paxinos &
Franklin, 2004) to locate the craniotomy over either the dLGN or the SC. For SC
injections, a midline incision was made in the skin over the skull, and a craniotomy
was performed at 0.5 mm anterior and 0.5 mm temporal to Lambda. A borosilicate
glass pipette (interior diameter of 40-50μm), filled with ~10 µL of Ringer's solution,
was positioned over the craniotomy and lowered between 800µm and 1200µm
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from the surface. The dLGN or SC was located by recording visually evoked
spiking activity as the pipette was lowered. The depth was recorded where clear
visually evoked responses were obtained and the Ringer’s pipette was removed.
A second pipette (interior diameter of 18-22 µm), filled with 3.0 µL of virus was
positioned at the same stereotaxic coordinates as the Ringer’s filled pipette and at
the same depth. Light-evoked responses also were used to refine pipette
placement. Using light pressure, 2-2.5μL of virus was injected into the SC. Mice
were recovered from anesthesia, the incision was closed with skin glue (VetBond,
3M, St. Paul, MN) and the animal was given a subcutaneous 100 μl dose of
Carprofen (1.25 mg/ml) (Putney, Portland, ME). Four weeks post injection, retinas
were dissected, quartered, and mounted for whole cell patch clamp.
Immunohistochemistry
After patch clamp recording, the pieces of retina with recorded and filled
RGCs (Lucifer Yellow and neurobiotin) were fixed in 4% paraformaldehyde for 12
minutes, washed three times with 0.01 M phosphate buffer saline (PBS), and
placed into a 24-well plate. Retina pieces were incubated in blocking solution
consisting of PBX (0.5% Triton-X 100 in PBS) and 10% normal serum (donkey or
goat) for 60 minutes. Each retina piece was then reacted with a combination of
primary antibodies to stain for the either GlyRα1, GlyRα2, GlyRα3, or GlyRα4 or a
combination of two GlyRαXs, and Lucifer yellow overnight at 4°C (Table 1). In the
case where the Lucifer yellow antibody was not compatible, streptavidin was used
to stain for the filled cell, but was added with the secondary antibodies. The single
GlyR antibody or combination of GlyR antibodies were selected based on our
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observed τdecay estimates that we matched with the τdecay estimates from the
literature (Table 3.2) (Gill et al., 2006; Majumdar et al., 2007; Majumdar et al.,
2009; Veruki et al., 2007; Wassle et al., 2009) The primary antibodies were washed
off by a series of washes with PBX. Afterwards, a combination of secondary
antibodies and Hoechst stain (or also streptavidin) in normal serum was added to
label the primary antibodies and left on the tissue overnight at 4°C (Table 3.2). The
Hoechst stain was used to label the DNA in the somas and distinguish between
the retina nuclear and plexiform layers. The tissue was then washed with PBS and
mounted onto a slide and covered using Vectashield (Vector Labs, Burlingame,
CA) clear mounting medium and a coverslip.

Table 3.2. Primary and Secondary Antibodies used for Immunohistochemistry
Ab host / type

Target

CONC.

Manufacturer

Catalog No.

mouse monoclonal 1°

GlyRα1

1:500

Synaptic systems

Cat # 146 111

goat polyclonal 1°

GlyRα2

1:50

Santa Cruz Biotech.

Cat #SC17279

rabbit polyclonal 1°

GlyRα3

1:100

Chemicon

Cat# AB5472

rabbit polyclonal 1°

GlyRα4

1:100

Chemicon

Cat# AB9696

Rabbit polyclonal 1°

Lucifer yellow

1:1000

ThermoFisher

Cat# A-5750

donkey / Alexa 555 2°

anti-mouse

1:200

Life Technologies

Cat# A31570

donkey / Cy3 2°

anti-goat

1:200

JAX ImmunoResearch

Cat# 115165003

goat / Cy3 2°

anti-mouse

1:200

JAX ImmunoResearch

Cat# 111165003

goat / Cy3 2°

anti-rabbit

1:200

JAX ImmunoResearch

Cat# 705165003

Hoescht

DNA cong.

1:1000

Life technologies

Cat# H3570

Streptavidin-Cy2

Neurobiotin

1:1000

JAX ImmunoResearch

Cat# 016220084

Confocal Image Acquisition and Colocalization Analysis
We imaged the filled RGCs, using an Olympus Fluoview FV1000 confocal
microscope with Fluoview software (Olympus, Tokyo, Japan) and characterized
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their soma and dendritic morphology. The depths of the RGC's dendritic
ramifications were measured relative to the top of the RGC layer and the bottom
of the INL. The dendritic arbor diameter was measured using the polygon
measurements tool in the Fluoview software. Each RGC's dendritic ramification
depth, dendritic arbor diameter, and light response were used to identify the
specific RGC type. Individual dendrites and puncta expression were imaged with
a 60x oil immersion objective (NA 1.4).
Expression of individual GlyRα subunits was evaluated using Imaris
software (Bitplane, Zurich, CH) on filled RGCs after immunohistochemical
reactions. To improve the sensitivity of our image analysis, images of cell dendrites
and GlyR puncta were deconvolved using constrained iterative deconvolution in
cellSens (Olympus, Tokyo, Japan). GlyR puncta (color channel 1) coincident on or
within dendritic processes (color channel 2) were counted and the length of the
dendritic process was measured using the Filaments tool. The counting process
was performed using one of two methods. The Imaris puncta co-localization tool
was used to count the puncta for the: ONα RGCs, ONTransient RGCs, OFFδ RGCs,
the GlyRα3 expression on the F-mini RGCs, and the ON SACs. The Imaris
surfaces (to identify puncta) and surface to filament co-localization tools were used
to count puncta on the: LED, UHD, HD, and for the expression measurement of
GlyRα2 on the F-mini RGCs. To determine specificity of the coincident puncta,
the puncta channel (channel 1) was rotated along its x/y axis and coincident GlyR
puncta were recounted. The “rotated” puncta represent an estimate of coincident
expression, i.e. puncta not expressed on the dendrite of the filled cell. The original
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puncta count was compared to the random puncta count using a one-tailed paired
t-test to verify positive puncta expression on the dendrite. Finally, the rotated
coincident puncta was subtracted from the “original” puncta density to provide an
estimate of “corrected” puncta density.
Whole Mount Retinal Preparation for Electrophysiological Recordings
Animals were dark adapted for 30 minutes, given an IP injection of a cocktail
of ketamine and xylazine, and sacrificed using cervical dislocation. The eyes were
enucleated, the front of the eye removed and the retinas dissected under dim red
light at room temperature. The retina was incubated in a solution of Ringer’s with
collagenase (241 units/mL) and hyaluronidase (34.5nM per mL) (Worthington
Biochemicals, Lakewood, NJ) for 10 minutes to break down and remove the
vitreous attached to the retina. Remaining vitreous was carefully removed and
retinas were washed 3 times with fresh oxygenated Ringers to eliminate the
enzymes. Retinal whole mounts were quartered and each piece was placed RGC
side up onto a cover slip and placed into an oxygenated chamber until used. To
record from RGCs, a harp was placed on top of the retina to stabilize it and the
coverslip was placed into a chamber (Cell MicroControls, Norfolk, VA) on the stage
of the microscope. Wholemounts were continuously bathed in an oxygenated
Ringer’s solution at 36°C. The Ringer’s solution was preheated to 36 o and the exact
temperature in the chamber controlled by a feedback controller (Cell
MicroControls, Norfolk, VA) in the chamber.
Electrophysiology and Pharmacology
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Recordings were performed under light-adapted conditions. Either GFP
fluorescent RGCs, or GFP fluorescent RGCs with rAAV infected nuclei, positive
for tdTomato expression, were targeted for whole cell patch recordings to record
spontaneous inhibitory postsynaptic currents (sIPSCs). Oxygenated Ringer’s bath
solution (in mM: 125 NaCl, 2.5 KCl, 2.0 CaCl2, 1.0 MgCl2, 20 D-glucose, and 1.25
NaH2PO4, and 26 NaHCO3) (Sigma-Aldrich, St. Louis, MO) was held at 36°C using
an NBD TC2 BIP (Bipolar) temperature controller (Cell MicroControls, Norfolk, VA).
The intracellular pipette solution consisted of (in mM: 12.5 CsCl, 107 CsOH, 107
D-Gluconic Acid, 10 Na+ HEPES, 10 BAPTA, 5 QX-314(Br), 4 ATP, and 0.5 GTP).
The solution also contained either (in mM: 2.2 Lucifer yellow or 12.4 neurobiotin),
which labelled the RGC’s complete dendritic arbor morphology. After obtaining a
gigaohm seal, the membrane was broken with swift negative pressure and the
membrane potential (VHold) was held at -60 mV. All recordings were sampled at 10
kHz and were filtered using a 4-pole Bessel filter.
Holding the RGC membrane potential at +15 mV (0mV after correcting for
the liquid junction potential), the reversal potential for cations, we isolated and
recorded inhibitory sIPSCs for 100 seconds in control Ringer’s solution. The RGC
membrane potential was stepped to -60 mV and GABAA and GABACR antagonists
(picrotoxin (PTX) [20 μM], and (1,2,5,6-Tetrahydropyridin-4-yl)methylphosphonic
acid (TPMPA) [50 μM], respectively) were added to the bath solution (Ringer’s) for
ten minutes. The RGC membrane potential was stepped back to +15 mV and
isolated glycinergic sIPSCs were recorded for 100 seconds. At the end of this
recording, we added the GlyR antagonist (strychnine (STRYCH) [10 μM]) to the
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bath with the GABA antagonists for 5 minutes, recorded residual sIPSCs for 100
seconds to verify if all sIPSCs were eliminated.
Visual Stimulation
Immediately after a whole cell configuration was achieved, we determined
the visually evoked responses of the RGC using a full field light stimulus. From this
response we classified RGCs as ON, OFF or ON/OFF where the cell responded
to the ONset of the light stimulus, the OFFset of the light stimulus, or both.
Electrophysiological Analysis
We used Mini Analysis software (Synaptosoft, Decatur, GA) to identify
sIPSCs and quantify their frequency, rise time, amplitude, and τdecay from 100
second long voltage clamp recordings of ooDS RGCs held at the reverse cation
potential. We first selected candidate sIPSC peaks whose amplitude exceeded a
minimum threshold of twice the root mean squared (RMS) of the noise in each
recording. The noise was usually between 1.5 and 5 pA. Each sIPSC that met this
criterion was then evaluated using a model that has a fast rise time (10-90% peak,
1-6 ms), a single peak, and a single exponential decay time (peak to 37% of peak
(D37), 2-120 ms). Each sIPSC that fit this model was counted as a sIPSC. From
this analysis, the frequency of glycinergic sIPSCs is calculated by the software
over the duration of the 100 second recording. Subsequently, isolated individual
glycinergic sIPSCs, with single peaks only, were examined and the τdecay and rise
time of each sIPSC were measured using a single exponential. Double or multipeaked sIPSCs were only in included in the frequency data since they cannot be
reliably measured for τdecay or rise time. The data of the sIPSCs from each cell was
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grouped with like cells and pharmacological conditions. The τdecay times of the
sIPSCs of these groups were compared using the Kolmogorov–Smirnov test. The
mean τdecay, rise time, frequency, and amplitude data of the sIPSCs of these
groups were compared using a one-way Analysis of Variance, with a Bonferroni
Post-Hoc test to compare the data for each cell type or the pharmacological
condition or genotype in which it was recorded.
RESULTS
All α RGCs (ONα, OFFα, OFFδ, and ONT) Express GlyRα1
Previously, we and others observed GlyRα1 mediated sIPSCs and
expression in OFFα RGCs (Zhang et al., Majumdar et al., 2007). We targeted
GFP+ cells (in PVCre/Thy1STP or W7 retinas) (Farrow et al., 2013; Sanes &
Masland, 2015) whose soma diameters were > 15μm and characterized their
GlyRα isoform-specific currents. Both reporter retinas contain GFP+ OFFα, ONα
and ONδ RGCs and the PVCre/Thy1STP reporter retina, also contains GFP+ ONTrans
(ONT) RGCs (Krieger et al., 2017). We confirmed our previous observation that
WT OFFα glycinergic sIPSCs have a mean decay time ( τdecay) of 2.6±0.1ms
(OFFα, N= 15) (C. Zhang et al., 2014) (Figure 3.1A-E).
All of the characteristics of the glycinergic sIPSCs in the four α RGCs were
similar (Figure 3.1; One-way Analysis of Variance, Bonferroni Post-Hoc tests). The
mean τdecay of glycinergic sIPSCs (Figure 1.1 B-E) were: 3.0±0.2 ms (ONα, N = 8),
2.9±0.2 ms (ONT, N = 10), and 2.7±0.2 ms (OFF𝛿, n = 8) (Figure 3.1D; p > 0.05).
The mean frequency of glycinergic sIPSCs were: 24.2±2.5 (ONα), 27.5±3.6 (ON T),
28.1±2.4 (OFFα), and 26.4±5.3 events/sec (OFF𝛿) (Figure 3.1F; p > 0.05). The
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mean glycinergic sIPSC amplitudes were similar: 42.7±6.0 (ONα), 52.1±10.0
(ONT), 69.6±14.3 (OFFα), and 87.4±18.0 pA (OFF𝛿) (Figure 3.1G; p > 0.05). The
mean glycinergic sIPSC rise times were similar: 1.7±0.2 (ONα), 1.3±0.2 (ON T),
1.7±0.3 (OFFα), and 1.9±0.3 ms (OFF𝛿) (Figure 3.1H; p > 0.05). Thus, we
hypothesized that ONα, ONT, OFFα, and OFF𝛿 RGCs express only GlyRα1.

Figure 3.1. In WT RGCs with the largest soma diameters Glycinergic sIPSCs are
fast and mediated by GlyRα1 A) Raw traces of glycinergic sIPSCs of ONα, ONT,
OFFα, and OFFδ RGCs in the presence of PTX and TPMPA to isolate GlyR53

mediated sIPSCs. The “ * ” indicates a glycinergic sIPSC. B) Average traces of
glycinergic sIPSCs of ONα, ONT, OFFα, and OFFδ RGCs. C) Cumulative
distribution of glycinergic sIPSC τdecay times (ms) for ONα, ONT, OFFα, and OFFδ
RGCs. The cumulative distributions among the different cell types were similar
(Kolmogorov–Smirnov test p < 0.05). D) The Mean glycinergic sIPSC τdecay for
ONα, ONT, OFFα, and OFFδ RGCs were all similar (p > 0.05, One-Way Analysis
of Variance, Bonferroni Post-Hoc test) E) Frequency distribution of glycinergic
sIPSC τdecay times indicating a similar distribution among the ONα, ONT, OFFα,
and OFFδ RGCs. F) Mean glycinergic sIPSC frequency (events/sec) for was
similar among the ONα, ONT, OFFα, and OFFδ RGCs, (p > 0.05, One-Way
Analysis of Variance, Bonferroni Post-Hoc test). G) The Mean glycinergic sIPSC
amplitude among the ONα, ONT, OFFα, and OFFδ RGCs was similar (p > 0.05,
One-Way Analysis of Variance, Bonferroni Post-Hoc test). H) Mean glycinergic
sIPSC rise time was similar among the ONα, ONT, OFFα, and OFFδ RGCs (p >
0.05, One-Way Analysis of Variance, Bonferroni Post-Hoc test).
To validate our recording results, we assessed GlyRα1 immunoreactivity on
the dendrites of ONα, ONT, OFFα, and OFF𝛿 RGCs. We measured the GlyRα1
puncta that colocalized with the dendrites of OFFα RGCs and confirmed our results
0.27±0.03 puncta∙μm-1 (OFFδ, N= 4 cells n=8 areas, data not shown) previously
published results (C. Zhang et al., 2014). The average GlyRα1-positive puncta
density on OFFα RGCs was similar to 0.3±0.03 (ONα, N=8, n=15), 0.14±0.02
(ONT, N=8, n=12), and 0.2±0.02 puncta∙μm-1 (OFF𝛿, N=9 n=16) (Figure 3.2C). We
estimated randomly associated GlyRα1-positive puncta and compared that density
to the original co-localized puncta and found that the randomly associated puncta
were significantly lower for each α RGC type (Figure 3.2C; p < 0.001). Finally, we
estimated the puncta density by subtracting random from co-localized puncta and
these also were similar across α RGCs: 0.15±0.02 (ONα, N=2, n=4), 0.09±0.02
(ONT, N=2, n=3), and 0.13±0.01 puncta∙μm-1 (OFF𝛿, N=2, n=4) including the
previously reported 0.21±0.2 puncta∙μm-1 (OFFα; (C. Zhang et al., 2014). These
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results are consistent with our electrophysiological recording and verify that only
GlyRα1 mediated glycinergic input is at αRGC synapses.

Figure 3.2. RGCs with the largest soma diameters Express GlyRα1. Ai-Aiii)
Wholemount images of ONα, ONT, and OFFδ RGCs filled with neurobiotin (scale
bar: 40μm). Bi-Biii) Wholemount images of ONα, ONT, and OFFδ RGC dendrites
stained for GlyRα1 expression (red) (Images and data sourced from (C. Zhang,
2015) (scale bar: 5μm). White arrows indicate representative co-localization of
GlyRα1. Ci-Ciii) Dendrites in WT ONα, ONT, and OFFδ RGCs have significantly
more GlyRα1 puncta density co-localization (μm-1) in the original (ORI)
orientation than coincidence co-localization in the flipped (RAN) orientation
(Wilcoxon Matched-pairs T-test). The corrected puncta density for these cells:
ONα is 0.15±0.02 μm-1, ONT is 0.09±0.02 μm-1, and OFFδ is 0.13±0.01 μm-1.

rAAV-Mediated RNAi Eliminates GlyRα1-Mediated sIPSCs in rAAV-Glra1-shRNA
Infected Α RGCs
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We used our successful knockdown approach (Zhang et al., 2014) to verify
our observations that all four α RGCs expressed only GlyRα1. We recorded
glycinergic sIPSCs in α RGCs infected with rAAV-Glra1-shRNA (Zhang et al.,
2014) to knockdown (KD) GlyRα1 expression and compared frequency in WT to
KD α RGCs. Representative recordings of GABAergic and glycinergic sIPSCs in
control solution are illustrated in Figure 3.3Ai and their absence is show when the
GABAergic antagonists PTX and TPMPA were added to the bath (3.3Aii). Virtually
no glycinergic sIPSCs remained in rAAV-Glra1-shRNA infected α RGCs was:
0.7±0.2 events/sec (ONα, N = 6), 0.9±0.2 events/sec (ONT, N = 9), 2.3.1±0.4
events/sec (OFFα, N = 6), and 1.2±0.4 events/sec (OFF𝛿, N = 4) (Figure 3.3B).
On average the reduction in sIPSCs was (97.2% reduction (ONα), 96.8% (ONT),
90.4% (OFFα), and 96.3% (OFFδ) (Figure 3.3A,B). These results show that ONα,
ONT, OFFα, and OFF𝛿 RGCs express only GlyRα1. Furthermore, the OFFα results
are similar to those found in (C. Zhang et al., 2014) where a ~95% reduction in
glycinergic sIPSC activity was found in the rAAV-Glra1-shRNA infected OFFα
RGCs.
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sIPSCs

GlyR sIPSCs

No sIPSCs

Figure 3.3. rAAV-Glra1-shRNA knocks down GlyRα1 expression in alpha and
delta RGCs. Ai) Raw traces of total sIPSCs of rAAV-Glra1-shRNA infected ONα,
ONT, OFFα, and OFFδ RGCs. Aii) Raw traces of glycinergic sIPSCs in rAAVGlra1-shRNA infected ONα, ONT, OFFα, and OFFδ RGCs recorded in the
presence of TPMPA and PTX. The vast majority of glycinergic activity is depleted
in these infected RGCs. Aiii) Raw traces recorded in rAAV-Glra1-shRNA infected
ONα, ONT, OFFα, and OFFδ RGCs in the presence of PTX/TPMPA/STYCH – no
sIPSCs were observed. The vast majority of glycinergic activity is depleted in
these infected RGCs. B) The mean glycinergic sIPSC frequency of both
uninfected and infected ONα, ONT, OFFα, and OFFδ RGCs. The mean infected
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RGC glycinergic sIPSC frequency was significantly less than the mean
uninfected RGC counterpart (***p < 0.0001, One-Way Analysis of Variance,
Bonferroni Post-Hoc test)
rAAV-Mediated RNAi Eliminates GlyRα1 Puncta Expression in Infected α RGCs
To validate the knockdown of Glra1 expression, we quantified coincident
GlyRα1 puncta on the dendrites of rAAV-Glra1-shRNA infected α RGCs (Figure
3.3A,B). When compared to uninfected PVCre/Thy1STP α RGCs, the rAAV-Glra1shRNA infected RGCs showed significantly lower puncta density (Figure 3.4B, p <
0.02, Unpaired Mann-Whitney Test). When corrected for chance coincidence,
there were very few GlyRα1-immunoreactive coincident puncta on the dendrites.
The average corrected GlyRα1 puncta coincidence was -0.004±0.002 (ONα), 0.006±0.007 (ONT), and 0.001±0.005 puncta∙μm-1 (OFF𝛿 RGCs) (Figure 3.4B).
Remaining GlyRα1 puncta found throughout the IPL but not on RGC dendrites
could be expression on amacrine or bipolar cells. Or, some GlyRα1-positive puncta
could also represent expression that was not fully eliminated by the Glra1-shRNA
(C. Zhang et al., 2014).
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Figure 3.4. GlyRα1 puncta expression is knocked down in rAAV-Glra1-shRNA
infected ONα, ONT, and OFFδ RGCs. Ai-Aiii) Wholemount images of ONα, ONT,
and OFFδ RGC dendrites (green) with GlyRα1 expression (red) (scale bar: 5μm).
White arrows indicate representative co-localization of GlyRα1. Bi-Biii) Dendrites
in ONα, ONT, and OFFδ RGCs with rAAV-Glra1-shRNA are similar between
GlyRα1 puncta density co-localization in the original (ORI) orientation and
coincidence co-localization in the rotated (RAN) orientation (Wilxocon Matchedpairs T-test). The corrected puncta density for these cells: ONα is -0.004±0.002
μm-1, ONT is -0.006±0.004 μm-1, and OFFδ is 0.001±0.005 μm-1. Ci-Ciii) The
corrected puncta density for the Glra1KDrAAV ONα, ONT, and OFFδ RGCs is
significantly lower than for WT RGCs (*p<0.05, **p<0.01, Two-Tailed Mann
Whitney U-test).

All Local Edge Detector, High Definition, and Ultra High Definition RGCs Express
GlyRα1 and GlyRα3
We examined the glycinergic isoform-specific expression and sIPSCs in
fluorescently labeled WT RGCs in W3 reporter mice (Jacoby & Schwartz, 2017; T.
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Kim, Soto, & Kerschensteiner, 2015). The GPF+ RGCs include three functional
types, local edge detector (LED), high definition (HD), and ultra-high definition
(UHD) RGCs. We compared the WT data across individual RGC types to
determine if they differed in their measured GlyR kinetics. We found no difference
in the glycinergic sIPSCs among these cells and we combined their results for the
remainder of the analysis (Supplemental Figure 1). The mean τdecay of the
glycinergic sIPSCs in all of the GFP+ RGCs was 7.5±0.2ms (Figure 3.5C), which
is similar to previously published values for GlyRα3 (Gill et al., 2006; Majumdar et
al., 2007) and significantly longer than the mean τdecay for α RGCs that express
GlyRα1 (Figure 3.5B,C; p < 0.003, Two-tailed Mann Whitey U-test (C)
Kolmogorov–Smirnov test p < 1.3e-121 (D). The frequency distribution of glycinergic
sIPSC τdecay times in W3 RGC appeared to display a skewed distribution (Figure
3.5D), indicating that not only the fast GlyRα3 mediates glycinergic synaptic
events, but a GlyRα isoform with different kinetics may also play a role.
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Figure 3.5. W3 RGCs appear to have GlyRα3-mediated sIPSCs. A) Raw traces
of W3 RGC glycinergic sIPSCs in PTX/TPMPA, and PTX/TPMPA/STRYCH. B)
Average traces of W3 (black) and ONα (grey) RGC glycinergic sIPSCs. C) The
mean glycinergic sIPSC τdecay of W3 RGCs is significantly slower than the ONα
RGCs (***p<0.003, Mann-Whitney U-test). D) Cumulative distributions of
glycinergic sIPSC τdecay times (ms) for W3 and ONα RGCs. The cumulative
distribution of glycinergic sIPSC τdecay in W3 RGCs is slower than the
representative GlyRα1 expressing ONα RGC (Kolmogorov–Smirnov test). E)
Frequency distribution of glycinergic sIPSC τdecay times for W3 RGCs (bin width is
1 ms).

WT W3 Glycinergic Synaptic Input is Mediated by GlyRα3, Glycinergic sIPSC
frequency is reduced in Glra3-/- W3 RGCs

61

Our electrophysiological data is consistent with the expression of GlyRα3 in
WT GPF+ W3 RGCs. To test this hypothesis, we recorded glycinergic sIPSCs in
Glra3-/-/W3 retinas (Jacoby & Schwartz, 2017; I. J. Kim et al., 2010). The frequency
of the glycinergic sIPSCs in Glra3-/-/W3 RGCs (regardless of RGC type) was
9.6±1.2 events/sec, which is significantly lower (~ 35%) than W3 WT RGCs, which
was 13.1±0.8 events/sec (Figure 3.6C; p < 0.01, One-way Analysis of Variance,
Bonferroni Post-Hoc test). This result supports the idea that GlyRα3 is expressed
by W3 RGCs, and the substantial frequency of the remaining glycinergic sIPSCs
indicates that a second glycine receptor also mediates synaptic events. None of
the sIPSC kinetics in the Glra3-/-/W3 differed significantly from WT. Further, the
frequency distributions of the τdecay of the WT and Glra3-/- did not differ. Because
neither decay frequency distribution had sIPSCs longer than 9ms, we
hypothesized that GlyRα1 also contributed to glycinergic synaptic input. We tested
this hypothesis and examined the rise time, amplitude, and decay characteristics
of the remaining glycinergic sIPSCs. The remaining sIPSCs in the Glra3-/- were
eliminated in the presence of strychnine (Figure 3.6A) In the Glra3-/-/W3 RGCs the
average glycinergic sIPSC rise time remained 3.3±0.3, which was the same as WT
RGCs, 3.1±0.3 (Figure 3.6D, p > 0.05, One-way Analysis of Variance, Bonferroni
Post-Hoc test). The mean glycinergic sIPSC amplitude was 21.3±2.7 pA, which
was also similar to WT at 23.3±1.4 pA (Figure 3.6E, p > 0.05, One-way Analysis
of Variance, Bonferroni Post-Hoc test). The mean glycinergic sIPSC τdecay in Glra3/-

W3 RGCs was 7.4±0.9 ms, and was similar to 7.5±0.9 ms in the WT (Figure 3.6F,

p > 0.05, One-way Analysis of Variance, Bonferroni Post-Hoc test). The cumulative
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glycinergic sIPSC τdecay distribution of the remaining glycinergic sIPSCs of the
Glra3-/-/W3 RGCs was also similar to the WT W3 RGCs (Figure 3.6F; Kolmogorov–
Smirnov test, p > 0.4). However, since the Glra3-/- W3 glycinergic sIPSC τdecay
distribution made no shift, it suggested the remaining glycinergic sIPSCs are
mediated by GlyRα1, whose mean τdecay is ~3 msec (Figure 3.6F). If the distribution
had shifted to the right it would indicate the remaining glycinergic sIPSCs were
slow such as GlyRα2 or GlyRα4. We tested this idea and infected WT W3 retinas
with rAAV-Glra1-shRNA.
Glycinergic sIPSC frequency is reduced in rAAV-Glra1-shRNA W3 RGCs
In rAAV-Glra1KD-shRNA infected WT GFP+ W3 RGCs, the glycinergic
sIPSC frequency was significantly lower than both WT and Glra3-/- (2.5±0.5
events/sec) (Figure 3.6C; p < 0.0001, One-way Analysis of Variance, Bonferroni
Post-Hoc test) and the cumulative glycinergic sIPSC τdecay in rAAV-Glra1-shRNA
infected W3 RGCs was significantly slower than WT, (Figure 3.6F; Kolmogorov–
Smirnov test, p < 4.95e-13). The mean τdecay was 10.1±1.0 ms, and was similar to
WT (Figure 3.6F, p > 0.05). Together these results indicate that GlyRα1 mediated
glycinergic synaptic inputs in W3 WT RGCs. In the absence of GlyRα1 expression,
did not alter either the rise time or the amplitude of the remaining glycinergic
sIPSCs compared to WT. Average rise time was 2.5±0.4 ms and amplitude was
26.9±3.1 pA (Figure 3.6D, F; p > 0.05 for both, One-way Analysis of Variance,
Bonferroni Post-Hoc test). To test the idea that both GlyRα3 and GlyRα1 are
expressed and mediate sIPSCs, we infected Glra3-/-/W3 retinas with the rAAVGlra1-shRNA, and characterized the remaining glycinergic sIPSCs.
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Glycinergic sIPSCs are eliminated in rAAV-Glra1-shRNA/Glra3 KO W3 RGCs
Glycinergic sIPSCs were eliminated in Glra3-/-/Glra1KD W3 RGCs (0.4±0.1
events/sec), which is statistically lower than WT and represents a 97% reduction
of sIPSCs from WT (Figure 3.6C; p < 0.0001, One-way Analysis of Variance,
Bonferroni Post-Hoc test). Together, these results indicate that W3 RGCs express
both GlyRα3 and GlyRα1. The few glycinergic sIPSCs that remained in Glra3-//Glra1KD W3 RGCs, could result from an incomplete knockdown of GlyRα1
receptors, consistent with our previous findings (Zhang et al., 2014).
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Figure 3.6. rAAV-mediated RNAi to Glra1 eliminates GlyRα1 sIPSC activity;
Glra3-/- eliminates GlyRα3 sIPSC activity, in W3 RGCs. A) Raw traces of total,
glycinergic (recorded in the presence of PTX/TPMPA), and strychnine sensitive
(recorded in the presence of PTX/TPMPA/STRYCH) sIPSCs of Glra3-/-, Glra1KD,
and Glra3-/-/Glra1KD W3 RGC. B) Average traces of WT (black), Glra3-/- (green),
and Glra1KD (purple) W3 RGC glycinergic sIPSCs. C) Mean glycinergic sIPSC
frequency (events/sec) for WT, Glra3-/-, Glra1KDrAAV, and Glra3-/-/Glra1KDrAAV
W3 RGCs. The average glycinergic sIPSC frequencies of Glra3-/- and
Glra1KDrAAV are significantly lower that WT, and the frequency in Glra3-//Glra1KDrAAV is almost zero (One-Way Analysis of Variance with Bonferroni
Post-Hoc test). D) Mean glycinergic sIPSC rise time (ms) for WT, Glra3-/-,
Glra1KDrAAV W3 RGCs is similar (One-Way Analysis of Variance with Bonferroni
Post-Hoc test). E) Average glycinergic sIPSC amplitude (pA) for WT, Glra3-/-,
Glra1KDrAAV W3 RGCs is similar (One-Way Analysis of Variance with Bonferroni
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Post-Hoc test). F) Cumulative distributions of glycinergic sIPSC τdecay times (ms)
for WT, Glra1KD, and Glra3-/- W3 RGCs. The cumulative distribution of glycinergic
sIPSC τdecay is significantly faster than WT in the Glra3-/- and significantly slower
than WT in the Glra1KDrAAV (Kolmogorov–Smirnov test). G) Mean τdecay is
similar among WT, Glra1KD, and Glra3-/- W3 RGCs (One-Way Analysis of
Variance with Bonferroni Post-Hoc test).
GlyRα1 but not GlyRα3 expression on WT W3 dendrites
Immunohistochemical analysis were used to assess GlyRα3 and GlyRα1
expression in WT W3 RGCs. The density of GlyRα3 puncta that co-localized with
W3 dendrites did not differ from randomly associated puncta (Figure 3.7B,Di).
GlyRα3 expression is dense throughout the IPL, although in a laminar pattern, and
our assay, microscope, and deconvolution analysis are sensitive enough to
adequately image these puncta. The W3 RGCs have dense bushy dendrites,
which confound this analysis, especially if the overall expression of GlyRα3 on
these cells is low, as indicated in the fact that Glra1KD reduces the glycinergic
sIPSC frequency more than the Glra3-/-. Similarly, immunohistochemical analysis
showed GlyRα1 expression co-localizes with W3 dendrites in both the original and
random configurations (Figure 3.7B,Dii). From our immunohistochemical analysis
of GlyRα1 expression on α RGCs, GlyRα1 puncta expression is dense throughout
the IPL and we successfully measured corrected puncta density. However, the W3
RGC bushy dense dendrites, and the possibility of low GlyRα1 expression on these
cells, may prevent our immunohistochemical analysis from being sensitive enough
to detect GlyRα1 puncta expression on W3 RGCs.
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Figure 3.7. GlyRα1 and GlyRα3 puncta are not detectable on W3 RGCs Ai-Aiii)
Wholemount image of W3 RGC (UHD RGC) (scale bar: 40μm). B) Wholemount
image of W3 RGC dendrites stained for GlyRα1 expression (red). White arrows
indicate representative co-localization of GlyRα1. C) Wholemount image of
Dendrites of W3 RGC dendrites stained for GlyRα3 expression (red) (scale bar:
5μm). Di) W3 RGCs have similar GlyRα3 puncta density co-localization (μm-1) to
coincidence co-localization in the flipped (RAN) orientation (Wilxocon Matchedpairs U-test). The corrected puncta density of GlyRα3 for W3 RGCs is 0.004±0.012 μm-1. Dii) W3 RGCs have similar GlyRα1 puncta density colocalization (μm-1) with coincidence co-localization in the flipped (RAN)
orientation (Wilxocon Matched-pairs U-test). The corrected puncta density of
GlyRα3 for W3 RGCs is 0.008±0.021 μm-1.

Asymmetric OFFT (F-mini) WT RGCs Glycinergic Synaptic Input is Mediated by
GlyRα2 and GlyRα3
We examined the glycinergic isoform-specific expression and synaptic
currents in F-mini RGCs that are GFP+ in PVCre/Thy1STP reporter mice. We
identified F-mini RGCs among other GFP+ RGCs because of their small somas
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(~10μm dia.), asymmetric dendritic arbor that ramified in the OFF sublamina of the
IPL and their OFFTransient visually-evoked responses. These cells also have been
referred to as PV7 RGCs (Farrow et al., 2013; Rousso et al., 2016). In the presence
of PTX [20μM] and TPMPA [50μm], the glycinergic sIPSCs in WT F-mini RGCs
had an average τdecay of 6.5±0.5 ms, similar to the average in W3 WT RGCs and
to published τdecay values for GlyRα3 mediated sIPSCs (Figure 3.8A-C) (Gill et al.,
2006; Majumdar et al., 2007). The frequency distribution of their τdecay appears to
be skewed and includes sIPSCs with decays slower than GlyRα1 or > 3 msec. We
considered that this could indicate expression of either GlyRα2 or GlyRα4 (Figure
3.8D).
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Figure 3.8. F-mini RGCs appear to have GlyRα3-mediated sIPSCs. A) Raw
traces of F-mini RGC glycinergic sIPSCs and strychnine sensitive sIPSCs. The “
* “ indicates a glycinergic sIPSC. B) Average traces of F-mini (black) and ONα
(grey) RGC glycinergic sIPSCs. C) Cumulative distributions of glycinergic sIPSC
τdecay times (ms) for F-mini and ONα RGCs. The cumulative distribution of
glycinergic sIPSC τdecay in F-mini RGCs is slower than the representative GlyRα1
expressing ONα RGC (Kolmogorov–Smirnov test). D) Frequency distribution of
glycinergic sIPSC τdecay times for F-mini RGCs (bin width is 1 ms). E) The mean
glycinergic sIPSC τdecay of F-mini RGCs is significantly slower than the ONα
RGCs (Mann-Whitney U-test).
Glycinergic sIPSC frequency is reduced in Glra3-/- F-mini RGCs
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To test the hypothesis that WT F-mini RGCs express GlyRα3, we recorded
glycinergic sIPSCs in Glra3-/- F-mini RGCs and found that their frequency was
significantly lower compared to WT (4.4±1.1 vs. 14.1±1.3 events/sec; respectively;
Figure 3.9C; p < 0.0001, One-way Analysis of Variance, Bonferroni Post-Hoc test).
The average τdecay of the remaining glycinergic sIPSCs (10.2±0.4 ms) was
significantly slower than WT (Figure 3.9F, p < 0.04, One-way Analysis of Variance,
Bonferroni Post-Hoc test) and the cumulative sIPSC τdecay curve was shifted to
larger values (Figure 3.9G, Kolmogorov–Smirnov test, p < 2.3e-74. We
characterized the remaining glycinergic sIPSCs and found their mean amplitude
was significantly lower than WT (21.8±2.8 vs 31.8±2.6 pA; respectively; Figure
3.9E, p < 0.002, One-way Analysis of Variance, Bonferroni Post-Hoc test). Their
rise time was similar to WT (2.5±0.4 vs 1.8±0.1 ms; respectively; Figure 3.9D, p >
0.05, One-way Analysis of Variance, Bonferroni Post-Hoc test). Together the data
suggest that WT F-mini’s express GlyRα3 and one of the glycine α subunits with
slow decay kinetics, GlyRα2 or GlyRα4.
Glycinergic sIPSC frequency is reduced in Glra2-/- F-mini RGCs
To test the hypothesis that GlyRα2 receptors mediate synaptic currents in
F-mini OFFTransient RGCs, we recorded sIPSCs in Glra2-/- F-mini RGCs. The
frequency of glycinergic sIPSCs was significantly less in Glra2-/- F-mini RGCs
(8.5±1.3 events/sec) compared to WT (14.1±1.3 events/sec); Figure 3.9C; p <
0.0001, One-way Analysis of Variance, Bonferroni Post-Hoc test). The average
Glra2-/- F-mini glycinergic sIPSC τdecay (7.8±0.4 ms) was similar to WT (Figure
3.9G,p > 0.05, One-way Analysis of Variance, Bonferroni Post-Hoc test) and
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surprisingly, their cumulative sIPSC τdecay curve shifted significantly to slower
values compared to WT (Figure 3.9F, Kolmogorov–Smirnov test, p < 2.46e-10).
This was surprising since GlyRα3-mediated sIPSCs are slower than WT and we
expected this curve to shift to slower values. The average rise time of the
glycinergic sIPSCs in the Glra2-/- F-mini RGCs was similar to WT and to Glra3-/(2.0±0.1 ms; Figure 3.9D, p > 0.05, One-way Analysis of Variance, Bonferroni
Post-Hoc test). The mean amplitude of Glra2-/- F-mini RGCs glycinergic sIPSCs
also was similar to WT (22.4±3.0 pA; Figure 3.9E, p > 0.05, One-way Analysis of
Variance, Bonferroni Post-Hoc test). These results suggest that both GlyRα2 and
GlyRα3 mediate synaptic inputs in F-mini RGCs.
Glycinergic sIPSC frequency is eliminated in Glra2-/-/Glra3-/- F-mini RGCs
When we recorded glycinergic synaptic inputs in Glra2-/-/Glra3-/- double KO
F-mini RGCs there were almost no sIPSCs (0.6±0.3 events/sec a decrease of ~
96%), which was significantly lower than WT and Glra2-/- F-mini RGCs (Figure
3.9C; p < 0.0001, One-way Analysis of Variance, Bonferroni Post-Hoc test). These
results combined with the puncta expression results demonstrate that F-mini
RGCs express both GlyRα2 and GlyRα3.
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Figure 3.9. F-mini RGC glycinergic sIPSC activity is eliminated in Glra2-/-/Glra3-/-.
A) Raw traces of total and glycinergic sIPSCs of Glra3-/-, Glra2-/-, and Glra2-//Glra3-/-F-mini RGCs. B) Average traces of WT (black), Glra3-/- (green), and
Glra2-/- (blue), F-mini RGC glycinergic sIPSCs. C) Mean glycinergic sIPSC
frequency (events/sec) for WT, Glra3-/-, Glra2-/-, and Glra2-/-/Glra3-/- F-mini RGCs.
The average glycinergic sIPSC frequencies of Glra3-/- and Glra2-/- are
significantly lower that WT, and the frequency in Glra2-/-/Glra3-/- is almost zero
(One-Way Analysis of Variance with Bonferroni Post-Hoc test). D) Mean
glycinergic sIPSC rise times (ms) for WT, Glra3-/-, Glra2-/-, and Glra2-/-/Glra3-/- Fmini RGCs are similar (One-Way Analysis of Variance with Bonferroni Post-Hoc
test). E) The Average glycinergic sIPSC amplitude (pA) for Glra2-/- is similar to
both WT, and Glra3-/- (One-Way Analysis of Variance with Bonferroni Post-Hoc
test). The average glycinergic sIPSC amplitude for Glra3-/- is significantly lower
than WT (One-Way Analysis of Variance with Bonferroni Post-Hoc test). F) The
mean glycinergic sIPSC τdecay time of the Glra3-/- F-mini RGC is significantly
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slower than WT, however no different from the Glra2-/- F-mini RGC. The Glra2-/F-mini RGC mean glycinergic sIPSCs τdecay time is similar to WT. G) Cumulative
distribution of glycinergic sIPSC τdecay times (ms) for WT, Glra2-/-, Glra3-/- F-mini
RGCs. The cumulative distribution of glycinergic sIPSC τdecay is significantly
slower in the Glra2-/-, Glra3-/-, and Glra2-/-/ Glra3-/- (Kolmogorov–Smirnov test).
GlyRα2 and GlyRα3 expression on WT F-mini dendrites
To validate our electrophysiological recordings, we assessed the
immunoreactivity of F-mini WT RGCs dendrites for GlyRα3 and GlyRα2 positive
puncta. We measured the density of each of these puncta and compared them to
an estimate of random puncta coincidence. Both GlyRα3 and GlyRα2 puncta
density was significantly higher than random coincidence (GlyRα3 0.16±0.01
puncta∙μm-1; GlyRα2 0.28±0.03 puncta∙μm-1; respectively (Figure 3.10Di, Dii, p <
0.0003; 0.0001 (paired one-tailed T-test). Their average corrected puncta density
was (GlyRα3 0.05±0.01 puncta∙μm-1; GlyRα2 0.22±0.02 puncta∙μm-1. These
results support our hypothesis that synaptic input to WT F-mini RGCs is mediated
by both GlyRα3 and GlyRα2.
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Figure 3.10. F-mini RGCs Express GlyRα2 and GlyRα3. (Images and GlyRα3
puncta count data sourced from (C. Zhang, 2015). A) Wholemount image of Fmini RGC filled with neurobiotin (scale bar: 40μm). B) Wholemount image of Fmini RGC dendrites stained for GlyRα3 expression (red) (scale bar: 5μm). White
arrows indicate representative co-localization of GlyRα3. C) Wholemount image
of F-mini RGC dendrites stained for GlyRα2 expression (red) (scale bar: 5μm).
White arrows indicate representative co-localization of GlyRα2. Di) Dendrites in
WT F-mini RGCs have significantly more GlyRα3 puncta density co-localization
(μm-1) than coincidence co-localization in the flipped (RAN) orientation (Wilxocon
matched-pairs U-test). The corrected puncta density for GlyRα3 puncta on F-mini
RGCs is 0.05±0.01 μm-1. Dii) Dendrites in WT F-mini RGCs have significantly
more GlyRα2 puncta density co-localization (μm-1) than coincidence colocalization in the flipped (RAN) orientation (Wilxocon matched-pairs U-test). The
corrected puncta density for GlyRα2 puncta on F-mini RGCs is 0.22±0.02 μm-1.
Glycinergic Synaptic Input to J-RGCs is Mediated by GlyRα2
We examined the glycinergic isoform-specific expression and sIPSCs in
asymmetric, intrinsically orientation selective J-RGCs. These were included in
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color encoding YFP+ J-RGCs in tamoxifen injected JAM-BCreER reporter mice
(Figure 3.11) (I. J. Kim, Zhang, Yamagata, Meister, & Sanes, 2008; Liu & Sanes,
2017; Sanes & Masland, 2015). In the presence of GABAAR and GABACR
antagonists, the average τdecay of glycinergic sIPSCs in WT J-RGCs was 23.3±0.5
ms (Figure 3.11B-D). The in presence of strychnine, all glycinergic sIPSCs were
eliminated Figure 3.11A). The slow τdecay indicates that synaptic glycinergic
currents in J-RGCs are mediated by either GlyRα2 or GlyRα4 whose mean sIPSC

τdecays are slower than τdecays mediated by either GlyRα1 or GlyRα3 (Figure
3.11B,C). Furthermore, the frequency distribution of J-RGC glycinergic sIPSC

τdecay is skewed and may represent the expression of more than one slow GlyR α
subunit (Figure 3.11D).
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Figure 3.11. J-RGCs appear to have GlyRα2 or GlyRα4-mediated sIPSCs. A)
Raw traces of J-RGC glycinergic sIPSCs. The “ * “ indicates a glycinergic sIPSC.
Glycinergic sIPSCs are isolated in the presence of PTX/TPMPA and eliminated
in the presence of PTX/TPMPA/STRYCH. B) Average traces of J-RGC (black),
W3 (green), and ONα RGC (grey) glycinergic sIPSCs. C) The mean τdecay of JRGC glycinergic sIPSCs is significantly more than the mean τdecay of both WT
and ONα RGCs (One-Way Analysis of Variance with Bonferroni Post-Hoc test).
D) Cumulative distributions of glycinergic sIPSC τdecay times (ms) for J-RGCs
(black), W3 RGCs (green) and ONα RGCs (grey). The cumulative distribution of
glycinergic sIPSC τdecay in J-RGCs is slower than both the representative GlyRα1
expressing ONα RGCs and the representative GlyRα3 expressing W3 RGCs
(Kolmogorov–Smirnov test). E) Frequency distribution of glycinergic sIPSC τdecay
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times for J-RGCs is skewed (bin width is 3 ms). F) Wholemount image of J-RGC
filled with Lucifer Yellow (scale bar: 50μm).
J-RGCs express GlyRα2
We tested the hypothesis that J-RGCs express GlyRα2 and recorded
glycinergic sIPSCs in Glra2-/-/J-RGCs and found the average frequency was
significantly less than WT (1.2±0.2 vs. 2.6±0.4 events/sec, respectively; Figure
3.12C; p < 0.001, One-way Analysis of Variance, Bonferroni Post-Hoc test). The
average Glra2-/-/J-RGC glycinergic sIPSC τdecay was significantly faster than WT
(16.3±0.6 ms; Figure 3.12D; p < 0.01, One-way Analysis of Variance, Bonferroni
Post-Hoc test). Similarly, the cumulative distribution curve of glycinergic sIPSC

τdecay in Glra2-/-/J-RGCs was shifted to faster decays compared to WT (Figure
3.12E; p < 8.14e-16, Kolmogorov–Smirnov test). The rise time of Glra2-/-- J-RGCs
was significantly slower than WT J-RGCs (4.9±0.4 vs 3.5±0.2, respectively; (Figure
3.12F, p < 0.05, One-way Analysis of Variance, Bonferroni Post-Hoc test) although
their amplitude was similar to WT (21.3±2.2 pA; Figure 3.12G, p > 0.05, One-way
Analysis of Variance, Bonferroni Post-Hoc test). These data suggest that the
remaining sIPSCs in Glra2-/- J-RGCs are mediated by GlyRα4 and we tested this
idea, by recording sIPSCs in Glra2-/-/Glra4-/- J-RGCs. These remaining glycinergic
sIPSCs were eliminated in the presence of strychnine (Figure 3.12A).
Glra2-/-/Glra4-/- J-RGCs Have Similar Synaptic Input to Glra2-/In Glra2-/-/Glra4-/- J-RGCs, the frequency of glycinergic sIPSC was
significantly lower compared to WT (0.7±0.1, a 72% reduction; Figure 3.12C; p <
0.01, One-way Analysis of Variance, Bonferroni Post-Hoc test). Although the
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frequency of glycinergic sIPSCs in Glra2-/-/Glra4-/- compared to Glra2-/- J-RGCs it
did not differ significantly (Figure 3.12C, p > 0.05, One-Way Analysis of Variance
with Bonferroni Post-Hoc test). The characteristics of the remaining glycinergic
sIPSCs were similar to WT, the average rise time of Glra2-/-/Glra4-/- J-RGCs
glycinergic sIPSCs was still slow, and the amplitude also did not vary (19.0±1.0;
Figure 3.12F,G, p > 0.05, One-way Analysis of Variance, Bonferroni Post-Hoc
test). While the average τdecay was similar to WT (Figure 3.12D; p < 0.05, One-way
Analysis of Variance, Bonferroni Post-Hoc test); the cumulative τdecay was
significantly slower compared to WT (Figure 3.12E, Kolmogorov–Smirnov test, p
< 5e-10). It is clear from these results that WT J-RGCs synaptic inputs are mediated
by GlyRα2. What remains to be tested is whether GlyRα4 also mediates J-RGC
glycinergic sIPSCs and if the puncta of GlyRα2 and GlyRα4 are colocalized on the
J-RGC dendrites.
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Figure 3.12. Glra2-/-/Glra4-/- eliminates glycinergic sIPSC activity in J-RGCs. A)
Raw traces of total and glycinergic sIPSCs of Glra2-/- and Glra2-/-/Glra4-/- J-RGCs.
GlyR sIPSCs are isolated in the presence of PTX/TPMPA and the all sIPSCs are
eliminated in the presence of PTX/TPMPA/STRYCH. B) Average traces of WT
(black), Glra2-/- (blue), and Glra2-/-/Glra4-/- (purple) J-RGC glycinergic sIPSCs. C)
The Mean glycinergic sIPSC frequency (events/sec) for WT, Glra2-/-, Glra2-//Glra4-/- J-RGCs. The average glycinergic sIPSC frequencies of Glra2-/- and
Glra2-/-/Glra4-/- are significantly lower that WT, however the glycinergic sIPSC
frequency was similar between the Glra2-/- and Glra2-/-/Glra4-/- (One-Way
Analysis of Variance with Bonferroni Post-Hoc test). D) The mean glycinergic
sIPSC τdecay time of the Glra3-/- F-mini RGC is significantly slower than WT,
however no different from the Glra2-/- F-mini RGC. The Glra2-/- F-mini RGC mean
glycinergic sIPSCs τdecay time is similar to WT. E) Cumulative distribution of
glycinergic sIPSC τdecay times (ms) for WT, Glra2-/-, and Glra2-/-/Glra4-/- J-RGCs.
The cumulative distribution of glycinergic sIPSC τdecay is significantly faster the
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Glra2-/-, then Glra2-/-/ Glra3-/- (Kolmogorov–Smirnov test). F) The mean rise times
(ms) of J-RGC glycinergic sIPSCs for WT, Glra2-/-, and Glra2-/-/Glra4-/-. The mean
Glra2-/- J-RGC glycinergic sIPSC rise time was significantly faster than WT (oneway analysis of variance with Bonferroni post-hoc test). G) The Average
glycinergic sIPSC amplitude (pA) for WT, Glra2-/-, and Glra2-/-/Glra4-/-was similar
among these three genotypes (One-Way Analysis of Variance with Bonferroni
Post-Hoc test).
WT ON SAC Glycinergic Synaptic Input is Mediated by GlyRα2
We targeted ON SACs using tdTomato+ ChAT-cre/ai9 mouse (Rossi et al.,
2011). In the presence of PTX [20μM] and TPMPA [50μm], ON SAC glycinergic
sIPSCs were slow and had an average τdecay of 28.4±0.7 ms, suggesting GlyRα2
and/or GlyRα4 mediate these synaptic events, and these events were eliminated
in the presence of strychnine (Figure 3.13A-D) It was previously reported that the
ON SACs express slow glycinergic sIPSCs (Majumdar et al., 2009). The frequency
distribution of the ON SAC glycinergic sIPSC τdecay shows a skewed distribution,
indicative of the expression of more than one kinetically disparate GlyR (Figure
3.13E).
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Figure 3.13. ON SAC glycinergic sIPSCs are slow and mediated by either
GlyRα2 or GlyRα4. A) Raw trace of glycinergic sIPSC of ON SACs. GlyR sIPSCs
are isolated in the presence of PTX/TPMPA and all sIPSCs are eliminated in the
presence of PTX/TPMPA/STRYCH. B) Average trace of ON SAC glycinergic
sIPSCs with similar GlyRα2 mediated J-RGC trace for reference. C) Cumulative
distribution of glycinergic sIPSC τdecay times (ms) for ON SAC and J-RGCs.
There is a significant difference between the different genotypes (Kolmogorov–
Smirnov test). D) Mean glycinergic sIPSC τdecay for ON SACs and J-RGCs were
similar (p > 0.05, Mann-Whitney t-test). E) Frequency distribution of glycinergic
sIPSC τdecay of ON SACs.
Glycinergic sIPSC frequency is reduced in Glra2-/-ON SACs
We characterized the remaining glycinergic sIPSCs in Glra2-/- ON SACs
and found that the average frequency was significantly lower compared to WT
(0.4±0.1 vs. 1.13±0.2 events/sec, respectively; Figure 3.14C, p < 0.002, One-way
Analysis of Variance, Bonferroni Post-Hoc test). The remaining glycinergic sIPSCs
were eliminated in the presence of strychnine (Figure 3.14A). As noted in the JRGCs, comparisons of the average of glycinergic sIPSC τdecays between Glra2-/and WT ON SAC were similar (25.72±0.92 ms vs.25.5±2.4 ms, respectively), but
the cumulative distribution curves of Glra2-/- and WT ON SACs differed significantly
and Glra2-/- ON SAC decays were faster (Figure 3.14F; Kolmogorov–Smirnov test,
p < 6.5e-5). Neither glycinergic sIPSC rise time (3.6±0.5 ms) nor amplitude
(18.9±1.5 vs 27.5±2.7 pA; Figure 3.14D,E, p > 0.05, One-way Analysis of Variance,
Bonferroni Post-Hoc test) of Glra2-/- ON SACs differed from WT. The significant
decrease in glycinergic sIPSC frequency suggests that WT ON SACs express
GlyRα2. The characteristics of the remaining Glra2-/- ON SAC glycinergic sIPSCs
indicates that their glycinergic synaptic inputs also might be mediated by GlyRα4.
Glycinergic sIPSC frequency is Not Reduced in Glra4-/-ON SACs
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We also recorded glycinergic sIPSCs in Glra4-/- ON SAC and found that
while the frequency was about half of WT, it was not statistically different (0.6±0.2
events/sec; Figure 3.14D; p > 0.05, One-way Analysis of Variance, Bonferroni
Post-Hoc test). The characteristics of the glycinergic sIPSCs in the Glra4-/- ON
SACs were all similar to WT and were eliminated in the presence of strychnine
(Figure 3.14A-F, p > 0.05 for all, One-way Analysis of Variance, Bonferroni PostHoc test).
Glycinergic sIPSCs are not reduced further in Glra2-/-/Glra4-/-ON SACs
We recorded glycinergic sIPSCs in the Glra2-/-/Glra4-/- ON SACs and while
their mean frequency was lower (0.3±0.1 events/sec) it did not differ significantly
from Glra2-/- or Glra4-/- single KO cells (Figure 3.14C; p < 0.0002, One-way
Analysis of Variance, Bonferroni Post-Hoc test). These remaining sIPSCs were
eliminated by strychnine (Figure 3.14A). The mean amplitude of the glycinergic
sIPSCs in Glra2-/-/Glra4-/- ON SACs was significantly lower than WT (16.8±1.1 pA;
Figure 3.14E, p < 0.02, One-way Analysis of Variance, Bonferroni Post-Hoc test),
which indicates a reduction in presynaptic glycine release and potential upstream
modifications. The rise time and the τdecay of the remaining glycinergic sIPSCs were
similar to WT (Figure 3.14D,F, p > 0.5 for both , One-way Analysis of Variance,
Bonferroni Post-Hoc test). The cumulative distribution of ON SAC glycinergic
sIPSC τdecay also was similar to Glra2-/- ON SACs (Figure 3. 14F, Kolmogorov–
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Smirnov test, p > 0.1). From these data, we conclude the ON SACs express
GlyRα2.

Figure 3.14. ON SAC glycinergic sIPSCs are slow and mediated by GlyRα2. A)
Raw traces of glycinergic sIPSCs of ON SACs in Glra2-/-, Glra4-/- and Glra2-//Glra4-/-. GlyR sIPSCs were isolated in the presence of PTX/TPMPA and all
sIPSCs were eliminated in the presence of PTX/TPMPA/STRYCH. B) Average
traces of ON SAC glycinergic sIPSCs in WT, Glra2-/-, Glra4-/- and Glra2-/-/Glra4-/-.
C) Mean glycinergic sIPSC frequency (events/sec) for WT, Glra2-/-, Glra4-/-, and
Glra2-/-/Glra4-/- ON SACs. The average glycinergic sIPSC frequencies
(events/sec) of Glra2-/- and Glra2-/-/Glra4-/- are significantly less than WT, the
latter being almost zero (one-way analysis of variance with Bonferroni post-hoc
test). D) Mean glycinergic sIPSC rise time (ms) for WT, Glra2-/-, Glra4-/-, and
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Glra2-/-/Glra4-/- ON SACs. All rise times observed were similar (p > 0.05, OneWay Analysis of Variance with Bonferroni Post-Hoc test). E) Mean amplitude
observed for the ON SACs in WT, Glra2-/-, Glra4-/- and Glra2-/-/Glra4-/-. Only the
mean amplitude (pA) in the Glra2-/-/Glra4-/- was significantly lower than WT (p <
0.02, One-Way Analysis of Variance with Bonferroni Post-Hoc test). F)
Cumulative distribution of glycinergic sIPSC τdecay times (ms) for WT, Glra2-/-,
Glra4-/-, and Glra2-/-/Glra4-/- ON SACs. The Glra2-/- and the Glra2-/-/Glra4-/- curves
were both significantly different from WT, but were similar to each other
(Kolmogorov–Smirnov test). G) The mean glycinergic sIPSC τdecay was similar
among the WT, Glra2-/-, Glra4-/-, and Glra2-/-/Glra4-/- ON SACs (p > 0.05, OneWay Analysis of Variance with Bonferroni Post-Hoc test).
GlyRα2 and GlyRα4 Expression on WT ON SACs processes
Previously published data reported that ON SACs express GlyRα4 (Heinze
et al., 2007; Majumdar et al., 2009; Weiss et al., 2008). Our electrophysiology data
suggest the ON SACs express GlyRα2, GlyRα4, or both. We examined puncta
expression on ON SACs express and found that the average GlyRα2-positive
puncta density coincident with ON SAC dendrites was 0.15±0.02 μm-1 and the
average random GlyRα2-positive puncta density was significantly less (0.08±0.01
μm-1; Figure 3.15C, Dii; p < 0.005, one tailed paired T-test). The average corrected
GlyRα2-positive puncta density was 0.07±0.01 μm-1 (Figure 3.15Dii). We also
found the average GlyRα4-positive puncta density coincident with ON SAC
dendrites was similar to that of GlyRα2 and was 0.17±0.02 μm-1. The average
random GlyRα4-positive puncta density was (0.12±0.03 μm-1) and significantly
lower than the original puncta density (Figure 3.15B, Di; p < 0.05, one-tailed paired
T-test). The average corrected GlyRα4-positive puncta density was 0.05±0.01
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(Figure 3.15Di). While the GlyRα2 expression supports our electrophysiological
data, more work is needed to reconcile the GlyRα4 expression on these ACs.

Figure 3.15. ON SACs Express GlyRα2 and GlyRα4 puncta. (Images sourced
from (C. Zhang, 2015). A) Wholemount image of ON SAC filled with neurobiotin
(scale bar: 40μm). B) Wholemount image of ON SAC dendrites stained for
GlyRα4 expression (red) (scale bar: 5μm). White arrows indicate representative
co-localization of GlyRα4. C) Wholemount image of ON SAC dendrites stained
for GlyRα2 expression (red) (scale bar: 5μm). White arrows indicate
representative co-localization of GlyRα2. Di) Dendrites in ON SACs have
significantly more GlyRα4 puncta density co-localization than coincidence colocalization in the flipped (RAN) orientation (Wilxocon matched-pairs U-test). The
corrected puncta density for GlyRα4 puncta on SACs is 0.05±0.01 μm-1. Dii)
Dendrites in SACs have significantly more GlyRα2 puncta density co-localization
(μm-1) than coincidence co-localization in the flipped (RAN) orientation (Wilxocon
matched-pairs U-test). The corrected puncta density for GlyRα2 puncta on SACs
is 0.07±0.01 μm-1.
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DISCUSSION
The four heteromeric GlyRs found in the retina have different decay kinetics,
and their expression is differential. One can speculate on GlyR inhibitory function,
but given the diversity of GlyR expression on the RGCs we assessed, their function
should be measured based on individual RGC specific GlyR expression and the
specific RGC type and visual response properties. Until recently, GlyR expression
on specific RGCs was only predicted and has been verified for one RGC, the OFFα
RGC (C. Zhang et al., 2014). Using a similar approach with rAAV-Glra1-shRNA to
knock down the expression of GlyRα1 and a variety of GlyR KO models, we
resolved the GlyR expression for a nine different RGCs and one AC that
encompass roughly 50% of all RGCs found in the mouse retina (Sanes & Masland,
2015), as well as the ON SAC. Our survey of GlyR expression in RGCs presents
an opportunity to elucidate the function of GlyRs in specific inhibitory circuits,
involving specific RGCs.
ONα, ONT, OFFα, and OFFδ RGC Glycinergic Synaptic Inputs
Our lab previously determined OFFα RGCs express GlyRα1, the GlyR with
the fastest kinetics (C. Zhang et al., 2014). Using the same approach, we
ascertained that all RGCs with the largest soma diameters (Onα, ONT, OFFα, and
OFFδ) express only GlyRα1. The τdecay of GlyRα1 mediated sIPSCs elsewhere in
the CNS is about 2-4 ms, thus our identification of GlyRα1 expression on the RGC
types with the largest somas is comparable to the kinetics of other confirmed
GlyRα1 mediated currents (Figure 3.1) (Legendre, 1999; Majumdar et al., 2007).
Furthermore, we assessed the GlyRα1-postive puncta on the α RGC dendrites,
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and positively identified its expression in WT α RGCs and its absence in rAAVGlra1-shRNA infected α RGCs. Zhang et al. previously determined that GlyRα1
input on OFFα RGCs helps modulate the spontaneous excitatory activity to
improve the signal to noise ratio, and slightly hyperpolarizes the cell reducing the
spiking probability. Furthermore, GlyRα1 input in OFFα RGCs helps diminish the
rebound excitation caused by the transient suppression of spiking from ON cone
bipolar cells during an OFFset stimulus. Finally, OFFα RGCs receive crossover
inhibition mediated by glycinergic input from the AII amacrine cell during the ONset
of light. It is very likely the role of GlyRα1 is similar in the other RGCs with the
largest somas where it modulates spontaneous activity, and the fidelity of spiking
responses is enhanced. However, further studies are necessary to elucidate the
function of GlyRα1 on the ONα, ONT, and OFFδ RGCs since their dendrites ramify
in different locations of the IPL, they likely receive input from glycinergic amacrine
cells other than the AII, and they are part of different parallel pathways.
W3 RGC Glycinergic Synaptic Input
Using our electrophysiological analysis we established that all fluorescent
RGCs found in the W3 reporter line express both GlyRα1 and GlyRα3; of the four
GlyRs these two have the fastest kinetics (Gill et al., 2006; Majumdar et al., 2007;
Majumdar et al., 2009). The established immunohistochemical approach we used
to identify GlyR puncta expression was not sensitive enough to positively identify
GlyRα1 and GlyRα3 on W3 RGCs. It is possible the GlyR expression on these
cells is lower than GlyR expression on other cells where we successfully identified
GlyR puncta expression. Additionally, each W3 RGC type has bushy and dense
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dendrites, which complicate our analysis where randomly associated puncta
expression could easily merge with a dendrite. Nevertheless, the drastic reduction
in glycinergic sIPSC activity in the Glra3-/- + rAAV-Glra1-shRNA indicate GlyRα1
and GlyRα3 are expressed on W3 RGCs.
All W3 RGCs (LED, HD, and UHD RGCs) have small somas, bushy
dendritic fields, and stratify in the middle of the IPL. Additionally, these cells
respond to both the ONset and OFFset of a receptive field center-sized spot
stimulus (Jacoby & Schwartz, 2017). However, each W3 RGC type differs in its
visual response kinetics, either sustained, transient, or a combination for the ON
and OFF responses. Since these RGCs express two GlyRs, it is possible each one
subserves a separate function, or a single function results from the complementary
interaction of both GlyRs. Since the W3 RGCs receive input from both the ON and
OFF pathway, it is likely that more sophisticated inhibitory synapses are required
to help modulate both of these inputs. It is feasible these two GlyRs have a role in
maintaining the spontaneous activity and improving the fidelity of the signal.
Moreover, though we concluded all W3 RGCs express both GlyRα1 and GlyRα3,
further study is needed evaluate the specific inhibitory function of these GlyRs on
the individual LED, UHD, and HD RGCs.
F-mini RGC Glycinergic Synaptic Input
The F-mini OFFT RGCs express both GlyRα2 and GlyRα3; a slow GlyR and
a fast GlyR, respectively (Haverkamp et al., 2004; Heinze et al., 2007; Majumdar
et al., 2009; Weiss et al., 2008; C. Zhang et al., 2015). We demonstrated the
puncta expression of both GlyRα2 and GlyRα3 on the dendrites of the F-mini
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RGCs. However, in the Glra3-/-, F-mini GlyR activity (which is presumed to be
mediated by GlyRα2) is much faster than isolated GlyRα2 activity observed in
other cells such as the ON SACs (Haverkamp et al., 2004; Weiss et al., 2008; C.
Zhang & McCall, 2012; C. Zhang et al., 2015). Perhaps the GlyRα2 expressed on
F-mini RGCs is a second splice variant with much faster kinetics than the
previously reported ~20-40 ms (Majumdar et al., 2009; Miller, Harvey, & Smart,
2004). Surprisingly, the F-mini glycinergic sIPSCs recorded in the Glra2-/-,
originating from GlyRα3 receptors, have a similar average τdecay to WT.
Furthermore, the cumulative distribution curve of the Glra2-/- glycinergic sIPSC

τdecay is shifted to the right from WT as opposed to the left. Thus, in the single KOs
of F-mini RGCs, the independent GlyRα2 and independent GlyRα3 decay kinetics
are slower than the complementary interaction of the two GlyRs in the WT F-mini
RGCs. Though this result is confusing, it is possible it is derived from a change
auxiliary protein modification of the remaining glycine receptor in the single KO, or
from an alteration from connatural receptor expression density on the F-mini RGC.
Further investigation using an rAAV-Glra2KD-shRNA or rAAV-Glra3KD-shRNA,
which only infects RGCs, may better demonstrate the function of GlyRs on F-mini
RGCs and also unveil how a global GlyR KO may disrupt spontaneous glycine
release onto the RGCs.
J-RGC Glycinergic Synaptic Input
Our evidence indicates J-RGCs express GlyRα2 since the glycinergic
sIPSC activity in Glra2-/- J-RGCs decreased significantly and the mean τdecay was
faster than WT. Glycinergic sIPSCs remained in the Glra2-/- so we measured
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synaptic glycinergic currents in the Glra2-/-/Glra4-/- but found little difference in
these measurements from the Glra2-/-. Our overall conclusion is J-RGCs express
GlyRα2. Despite the low glycinergic sIPSC frequency in the Glra2-/- and Glra2-//Glra4-/-, it is apparent that kinetically slow glycinergic sIPSCs remain. It is also
curious that the remaining J-RGC glycinergic sIPSCs in the Glra2-/-/Glra4-/- have a
mean τdecay similar to WT. Further investigation is needed to identify the remaining
GlyR expression on J-RGCs, including an immunohistochemical analysis of GlyR
puncta expression.
ON SAC Glycinergic Synaptic Input
We demonstrated using immunohistochemistry that ON SACs express both
GlyRα2 and GlyRα4; the two kinetically slow GlyRs. Curiously, our glycinergic
sIPSC analysis determined the ON SACs only express GlyRα2. All authors
investigating the glycinergic inhibition of ON SACs established these cells express
GlyRα4

(Majumdar

et

al.,

2009;

Weiss

et

al.,

2008).

Furthermore,

immunohistochemical experiments indicate that there is dense GlyRα4 expression
in the ON ChAT band, which increases the likelihood of GlyRα4 expression on any
dendrites of cells that ramify in this location, such as the ON SACs (Haverkamp,
1995; Heinze et al., 2007; Majumdar et al., 2009; Nobles et al., 2012; Weiss et al.,
2008). This discrepancy we observed may result from our electrophysiological
assay being less sensitive for cells types that exhibit a low glycinergic sIPSC
frequency. It is also important to take into consideration the global loss of GlyRs in
these KO models. Some glycinergic ACs express GlyRα2 and others may also
express GlyRα4 rendering contrasting electrophysiological results of our ON SAC
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analysis while using global KOs. Considering the established expression of
GlyRα4 on ON SACs, our demonstration of GlyRα2 and GlyRα4 puncta expression
on ON SACs, and our electrophysiological evidence of GlyRα2-mediated sIPSCs
from ON SACs, we conclude they express GlyRα2 and likely express GlyRα4.
The displaced ON SACs synaptically connect to the dendrites of the ON
sublamina of the ON/OFF direction selective RGCs, and release GABA to facilitate
direction selectivity (Rivlin-Etzion, Wei, & Feller, 2012; Wei & Feller, 2011; Wei,
Hamby, Zhou, & Feller, 2011). Experiments blocking GlyR activity indicate GlyRs
do not affect direction selectivity (Caldwell & Daw, 1978; Caldwell et al., 1978).
Nevertheless, GlyR expression of two different GlyRs in ON SACs suggest the
implicit need for inhibitory regulation to maintain the timing of GABA release.
Further investigation is required to determine the explicit roles GlyRα2 and GlyRα4
perform in modulating the output of ON SACs. Experiments assessing the
spatiotemporal visual response properties of these cells in WT, Glra2-/-, Glra4-/-,
and Glra2-/-/Glra4-/- will help indicate, through a loss of function approach, the
individual roles of these GlyRs in ON SACs.
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CHAPTER IV
GLYCINE RECEPTOR SUBUNIT EXPRESSION IN MOUSE RETINAL ON-OFF
DIRECTION SELECTIVE GANGLION CELLS
INTRODUCTION
In the retina, inhibition is mediated by both γ-aminobutyric acid (GABA)ergic
and glycinergic neurotransmission. Like the GABA receptor, glycine receptors
(GlyRs) are heteropentameric chloride ion channels comprised of β and α subunits
in a stoichiometry of 3β:2α. There is only one β subunit, but there are four different
α subunits (α1, α2, α3, α4) making four different GlyRs (Cascio, 2006; Lynch,
2004). It is clear from the published literature that the four glycine receptor subunits
(GlyRα1-4) are differentially expressed across the sublaminae of the retina’s IPL
(Haverkamp, 1995; Nobles et al., 2012; Veruki et al., 2007; Wassle et al., 2009). It
is also established that retinal cells such as OFF cone BCs and rod BCs express
GlyRα1, some narrow-field ACs express GlyRα2, while another narrow-filed AC,
the AII amacrine cell, likely expresses GlyRα3 and or GlyRα1, and the wide-field
starburst ACs express GlyRα4 (Gill et al., 2006; Haverkamp et al., 2004; Majumdar
et al., 2009; Weiss et al., 2008). However, cell type-specific GlyR expression on
retinal ganglion cells (RGCs) is less sufficiently characterized.
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The RGCs represent the culmination of retinal signal processing. They
process, filter, interpolate, and relay an ever-changing visual scene to the rest of
the brain. Using spiking signals that arise through the interplay of direct excitatory
and inhibitory inputs, from bipolar cells (BCs) and amacrine cells (ACs),
respectively. The RGCs form parallel circuits of information flow that arise in the
retina and lay the foundation for visual perception. Of the roughly forty different
RGC types, one of the most prominent types in the mouse retina is the ON/OFF
direction selective (ooDS) RGC (Baden et al., 2016; Bae et al., 2018; Jacoby &
Schwartz, 2017; Rivlin-Etzion et al., 2011; Sanes & Masland, 2015), which
represents about 20% of all RGCs in the mouse retina (Sanes & Masland, 2015).
The four types of ooDS RGCs each encode motion in one of the four cardinal
directions. It is clear from the published literature that GABAergic mediated
inhibition is crucial for both direction selectivity and response sensitivity in all ooDS
RGCs, and GABAA receptor (GABAAR) activity promotes transient ON and OFF
responses (Caldwell et al., 1978). However, much less is known about the role of
glycinergic inhibition on the visual response properties of ooDS RGCs, although in
the rabbit, intravitreal injections of strychnine, a glycine receptor antagonist,
reduced ooDS RGC response sensitivity and decreased the timing of the OFF
responses (Caldwell et al., 1978). In these studies, glycinergic inhibition was
eliminated throughout the retina and consequently we cannot pinpoint the effects.
They could result from direct glycinergic inhibition onto the ooDS RGCs or through
glycinergic inhibition in the circuit(s) that modulate the direct excitatory and/or
inhibitory inputs to these cells.
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To determine if ooDS RGCs receive direct glycinergic synaptic input, we
recorded spontaneous inhibitory postsynaptic currents (sIPSCs) and isolated
glycinergic sIPSCs using GABAA and GABAC receptor antagonists. All ooDS
RGCs receive glycinergic synaptic inputs, whose average τdecay is slow, about
20ms. These slow decay kinetics indicates that synaptic inputs are mediated by
GlyRα4 or GlyRα2. We tested this idea by eliminating the expression of both alpha
receptors, using Glra4-/-, Glra2-/- and Glra4-/-/Glra2-/- mouse models. We also
eliminated GlyRα4 expression using retrogradely transported rAAV-Glra4KDshRNA or rAAV-Glra2KD-shRNA, respectively. We confirmed the expression by
using immunohistochemistry and confocal microscopy. GlyR expression in ooDS
RGCs is consistent with our electrophysiological assessments.
MATERIALS AND METHODS
Animals
We used two reporter lines to target ooDS RGCs. Thyrotropin-releasing
hormone receptor (TRHR-GFP) retinas express GFP in identified ooDS RGCs with
a direction preference to posterior motion (Rivlin-Etzion et al., 2011). B6Pvalbtm1(cre)Arbr/J/Thy1STP-EYFP(PVCre/Thy1STP) reporter mice express YFP in eight
different RGCs, including ooDS RGCs representing all four cardinal directions
(Farrow et al., 2013; Hippenmeyer et al., 2005). Both TRHR and PVCre/Thy1STP
mice were crossed and backcrossed to Glra2-/-, Glra4-/-, and Glra2-/-/4-/- to obtain
GlyR global knockout models with labeled RGCs. All experiments were carried out
in accordance with the Association for Research in Vision and Ophthalmology
(ARVO) Statement for the Use of Animals in Ophthalmic and Visual Research and
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with the approval of the Institutional Animal Care and Use Committee (IACUC) of
the University of Louisville.
Viral Vector Construction and rAAV Production
To eliminate glycine receptor expression in the ooDS RGCs only, we used
a retrogradely transported rAAV virus containing shRNAs to Glra4. This approach
was used previously to knockdown expression of Glra1 (Zhang et al. 2014). Briefly,
we used our rAAV-Glra1-shRNA, an rAAV virus containing the shRNA Glra1, and
switched out the shRNA target of Glra1 for Glra4 (29mer in the pGFP-V-RS vector,
Origene, Rockville, MD). The new plasmid included: flanking Inverted terminal
repeats, elongation factor-1 promoter, a tdTomato gene with a nuclear localization
sequence, woodchuck hepatitis post-transcriptional regulatory element, a
polyadenylation site to protect the mRNA from degradation, the H1 promoter and
the Glra4-shRNA cassette (Figure 4.1). The plasmids were packaged into the
recombinant 2/7 rAAV vector serotype using a standard triple-plasmid protocol by
co-transfection of HEK293T cells to create the rAAV-Glra4KD-shRNA (Grieger,
Soltys, & Samulski, 2016; McClements & MacLaren, 2013; Reid & Lipinski, 2018).
The creation of these plasmids was performed by the Gregg Lab (University of
Louisville, Louisville, KY), and the virus was packaged by the Lipinski (Medical
College of Wisconsin, Milwaukee, WI), or Roska Labs (Friedrich Miescher Institute,
Basel Switzerland) labs.
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Figure 4.1. Schematic diagram of plasmid delivered via rAAV, used to change the
expression of GlyRα4 in ooDS RGCs. pAAV-Ef1a-NLStdTomato-H1 with Glra4KD
shRNA (rAAV-Glra4KD-shRNA; 3.28x1012 vg/mL).
Viral Injections in SC or dLGN
The methods to inject rAAV into the dorsal lateral geniculate nucleus
(dLGN) are published (Zhang et a., 2014). In many mice (aged between P30 and
P45), we performed rAAV injections into the superior colliculus (SC) instead. Mice,
were

anesthetized

using

the

administration

of

an

intramuscular

(IM),

intraperitoneal (IP) injection of a mixture of ketamine (70mg/kg) (VetaKet, Akorn,
Lake Forest, IL) and xylazine (12mg/kg) (AnaSed, LLOYD, Shenandoah, IA). Their
scalps were shaved, heads secured in a stereotaxic with ear cups and a bite bar,
and their body temperature (37oC) was maintained with a feedback controlled
heating pad. Eyes were lubricated with 1.3% polyvinyl alcohol and corneas were
protected with plastic contact lenses. Stereotaxic coordinates (Paxinos & Franklin,
2004) were used to locate a craniotomy over the SC. A midline incision was made
in the skin over the skull, and a craniotomy was performed at 0.5 mm anterior and
0.5 mm temporal to Lambda. A borosilicate glass pipette (interior diameter of 4050μm), filled with ~10 µL of Ringer's solution, was positioned over the craniotomy
and lowered between 800µm and 1200µm from the surface. Ringer’s solution
consisted of (in mM: 125 NaCl, 2.5 KCl, 2.0 CaCl2, 1.0 MgCl2, 20 D-glucose, and
1.25 NaH2PO4, and 26 NaHCO3) (Sigma-Aldrich, Burlingame, CA). The SC was
located when a clear visually evoked response was recorded through the pipette.
The depth of the SC was recorded, the Ringer’s pipette removed and a second
pipette (interior diameter of 18-22 µm), filled with 3.0 µL of rAAV diluted in HBSS
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(titer for each virus used listed in Figure 4.1) and positioned at the same stereotaxic
coordinates of the Ringer’s pipette. Light responses also were recorded again to
confirm placement of the rAAV pipette. Using light pressure, 2-2.5μL of rAAV
solution was injected into the SC and the pipetted removed. The incision was
closed with skin glue (VetBond, 3M, St. Paul, MN), the animal was given a
subcutaneous 100 μl dose of Carprofen (1.25 mg/ml) (Putney, Portland, ME) and
were recovered from anesthesia.
Wholemount Retinal Preparation for Electrophysiological Recordings
Four weeks post injection, animals were dark adapted for 30 minutes, given
an IP injection of a cocktail of ketamine/xylazine (409mg/kg and 54mg/kg,
respectively) and sacrificed using cervical dislocation. The eyes were enucleated,
the front of the eye removed and the retinas were incubated in a solution of
Ringer’s with collagenase (241 units/mL) and hyaluronidase (34.5nM per mL)
(Worthington Biochemicals, Lakewood, NJ) for 10 minutes to break down and
remove the vitreous attached to the retina. Remaining vitreous was carefully
removed and retinas were washed 3 times with fresh oxygenated Ringer’s to
eliminate the enzymes. Then, the retinas were quartered and each piece was
placed RGC side up onto a cover slip, a harp was placed on top of the retina to
stabilize it, and the apparatus was placed into a chamber (Cell MicroControls,
Norfolk, VA) on the stage of the microscope. Wholemounts were continuously
bathed in oxygenated Ringer’s solution at 36°C. The Ringer’s solution was
preheated to 36o and the exact temperature in the chamber controlled by an NBD
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TC2 BIP (Bipolar) feedback controller (Cell MicroControls, Norfolk, VA) in the
chamber.
Electrophysiological Recordings of RGCs and Pharmacology
RGCs were visualized on a Nikon Eclipse E600FN microscope with a Nikon
Fluor 60x water immersion objective with Hoffman Modulation Contrast (Nikon,
Tokyo, Japan). We targeted fluorescent GFP+ ooDS RGCs in PVCre/Thy1STP or
TRHR reporter mice and in rAAV infected retinas, we targeted double labeled
ooDS RGCs; GFP+ (green) from the reporter gene and tdTomato+ (red) nuclei
from rAAV infection. Glass electrodes were pulled from Kwik-Fil borosilicate glass
capillaries (1B150F-4, World Precision Instruments, Sarasota, FL) on a P-97
Flaming/Brown micropipette puller (Sutter Instruments, Novato, CA). The
resistance of these glass electrodes was 5-7 MΩ. Electrodes were filled with an
intracellular solution that consisted of: (in mM) 12.5 CsCl, 107 CsOH, 107 DGluconic Acid, 10 Na+ HEPES, 10 BAPTA, 5 QX-314(Br), 4 ATP, and 0.5 GTP 5
lidocaine N-ethyl bromide (QX314-Br) (Sigma-Aldrich, St. Louis MO), 2.2 Lucifer
yellow (Fisher Scientific, Hampton, NH) or 12.4 neurobiotin (Vector Labs,
Burlingame, CA) (pH 7.2 adjusted with CsOH).
After obtaining a gigaohm seal, the membrane was broken with swift
negative pressure, and the membrane potential (VHold) was held at -60 mV. All
recordings were sampled at 10 kHz. First, a light emitted diode (LED) was
positioned 2 cm above the tissue and presented a full field stimulus (3.7E 03 R*).
The stimulation protocol consisted of: a single 30ms light pulse, followed by a 2
second interstimulus interval (ISI), which was then followed by a five presentations
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of a 2 second light pulse with a 20 second ISI. The responses to the five, 2 second
light stimuli were averaged, analyzed using Clampfit software (Molecular Devices,
San Jose, CA) and used to determine if the RGC had an ON/OFF response.
We then characterized the sIPSCs in each ooDS RGC. The cell membrane
potential was held at +15 mV, the cation reversal potential, and total sIPSCs
(GABAergic and glycinergic) were recorded for 100 seconds and the membrane
potential lowered back to -60 mV. GABAA and GABACR antagonists (picrotoxin
(PTX) [20 μM], and (1,2,5,6-Tetrahydropyridin-4-yl)methylphosphonic acid
(TPMPA) [50 μM], respectively) were added to the bath solution (Ringer’s) for ten
minutes to isolate glycinergic sIPSCs. The RGC membrane potential was raised
to +15 mV and isolated glycinergic sIPSCs recorded for 100 seconds. To verify
that we had isolated glycinergic sIPSCs, the GlyR antagonist (strychnine
(STRYCH) [10 μM]) was added to the bath containing the GABA antagonists and
5 minutes later the cell was held at +15 mV for 100 seconds. Residual sIPSCs
were never recorded in the presence of GABA and GlyR antagonists.
Signal was monitored and recorded using an Axon Multiclamp 700B patch
clamp amplifier (Molecular Devices, San Jose, CA). The signals were digitized at
10 kHz using an Axon Digidata 1322A and visualized using Clampex 10.2 software
(Molecular Devices, San Jose, CA). To isolate sIPSCs, RGCs were held at the
cation reverse potential (VHold) of +15 mV (0mV after correcting for the liquid
junction potential).
Electrophysiological Data Analysis
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We used Mini Analysis software (Synaptosoft, Decatur, GA) to identify
sIPSCs in ooDS RGCs. First, we selected candidate sIPSC peaks whose
amplitude exceeded a minimum threshold of twice the root mean squared (RMS)
of the noise in each recording (between 1.5 and 5 pA). All the sIPSCs selected
were used to evaluate the frequency (events/sec) for the 100 second recording.
Next, these sIPSCs were further evaluated using a model sIPSC with a fast rise
time (10-90% peak, 1-6 ms), a single peak, and a single exponential decay time
(peak to 37% of peak (D37), 2-120 ms). Double or multi-peaked sIPSCs were only
in included in the frequency measurement; they were subsequently eliminated
because their kinetics and amplitude measurements are unreliable. The remaining
single peak sIPSCs were used in the analyses of the rise time, τdecay, and
amplitude of the sIPSCs. SIPSCs were never found in our +15 mV recordings with
both GABA and GlyR antagonists in the bath.
Immunohistochemistry and Confocal Imaging
After patch clamp recording, the pieces of retina with recorded and filled
RGCs (Lucifer Yellow and neurobiotin) were fixed in 4% paraformaldehyde for 12
minutes, washed three times with 0.01 M phosphate buffer saline (PBS), and
placed into a 24-well plate. Retina pieces were incubated in blocking solution
consisting of PBX (0.5% Triton-X 100 in PBS) and 10% normal serum (donkey or
goat) for 60 minutes. Each retina piece was then reacted with a combination of
primary antibodies to stain for the either GlyRα2or GlyRα4 or a combination of
both, and Lucifer yellow overnight at 4°C (Table 4.1). In the case where the Lucifer
yellow antibody was not compatible, streptavidin was used to stain for the filled
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cell, but was added with the secondary antibodies. The single GlyR antibody or
combination of GlyR antibodies were selected based on our observed τdecay
estimates that we matched with the τdecay estimates from the literature (Table 4.1)
(Haverkamp et al., 2004; Heinze et al., 2007; Majumdar et al., 2009; Wassle et al.,
2009). The primary antibodies were washed off by a series of washes with PBX.
Afterwards, a combination of secondary antibodies and Hoechst stain (or also
streptavidin) in normal serum was added to label the primary antibodies and left
on the tissue overnight at 4°C (Table 4.1). The Hoechst stain was used to label the
DNA in the somas and distinguish between the retina nuclear and plexiform layers.
The tissue was then washed with PBS and mounted onto a slide and covered using
Vectashield (Vector Labs, Burlingame, CA) clear mounting medium and a
coverslip.

Table 4.1. Primary and Secondary Antibodies used for Immunohistochemistry
Primary Antibodies
anti-Lucifer Yellow
anti-GlyRα2
anti-GlyRα4
Secondary Antibodies
anti-goat IgG Cy3
anti-rabbit IgG 488
streptavidin Cy2 or 633
Hoechst nuclear stain

Concentration
1:1000
1:50
1:100
Concentration
1:200
1:200
1:200
1:1000

Host
rabbit polyclonal
goat polyclonal
rabbit polyclonal
Host
donkey polyclonal
donkey polyclonal
conjugate
conjugate

Manufacturer
Life Technologies
Santa Cruz Biotech
Chemicon
Manufacturer
Jackson ImmunoResearch
Jackson ImmunoResearch
Life Technologies
Life Technologies

The recorded and filled ooDS RGCs were imaged using an Olympus
FV1000 confocal microscope. Whole RGC images were acquired using a 40x
water immersion (NA 1.15) objective and dendrites and GlyR puncta expression
were acquired using a 60x oil immersion (NA 1.4) objective. Images of ooDS RGC
dendrites were recorded with Fluoview software (Olympus, Tokyo, Japan). The
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depths of the RGC’s dendritic ramifications were measured relative to the top of
the RGC layer and the bottom of the INL. The combination of each RGC’s dendritic
ramification depth, dendrite arbor diameter, and light response were used to
identify and verify that the RGC was an ooDS RGC.
Colocalization Analysis of GlyRs on ooDS RGCs
Expression of GlyRs were characterized in recorded/filled ooDS RGCs.
Images of ooDS RGC dendrites and GlyR puncta were deconvolved, using
constrained iterative deconvolution in cellSens (Olympus, Tokyo, Japan). Using
the Imaris (Bitplane, Zurich, Switzerland) co-localization tool, coincident GlyR
puncta (color channel 1) on or within dendritic processes (color channel 2) were
counted and the length of the dendritic processes within the image was measured
using the filaments tool. The coincident puncta divided by the dendritic length
estimated puncta density. To determine which puncta were colocalized onto the
dendrite, the puncta channel (channel 1) was flipped along the xy axis and
coincident GlyR puncta were recounted. Then, the “flipped” or chance (RAN)
puncta density was subtracted from the “original” (ORI) puncta density and the
result estimated the “corrected” puncta density.
Statistical Analysis
The data of the sIPSCs from each cell was grouped with like cells and
pharmacological conditions. The cumulative distribution of the τdecay of the sIPSCs
of these groups were compared using the Kolmogorov–Smirnov test. The mean

τdecay, rise time, frequency, and amplitude data of the sIPSCs of these groups were
compared using a one-way Analysis of Variance, with a Bonferroni Post-Hoc test
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to compare the data for each cell type or the pharmacological condition or
genotype in which it was recorded. The Glra2-/-/Glra4KD data was compared to the
Glra4-/-/Glra2-/- using a Two-tailed Mann-Whitney test. The ORI and RAN puncta
density counts were compared using a paired Wilcoxon matched–pairs t-test.
Finally, the corrected puncta density among three groups was compared using a
Kruskal-Wallis One Way ANOVA test.
RESULTS
sIPSCs Indicate ooDS RGCs Express GlyRα2 and/or GlyRα4
We examined the glycinergic isoform specific expression and sIPSCs in
ooDS RGCs, which were identified by their GFP expression in either TRHR or
PVCre/Thy1STP mouse lines. We identified ooDS RGCs as GFP+ medium-sized
soma (~15μm in dia.) RGCs with ON/OFF light evoked responses and bistratified
dendritic sublamina. In WT ooDS RGCs, the total sIPSCs (Figure 4.2Ai, sIPSCs)
were a mixture of very slowly decaying, large amplitude sIPSCs and smaller
amplitude rapidly decaying sIPSCs. In the presence of strychnine, the GABAergic
sISPCs consisted of large rapid rise, slow decaying currents (Figure 4.2Aii, GABA
sIPSCs). In the presence of GABAR antagonists (picrotoxin and TPMPA) the large,
slow currents were eliminated (Figure 4.2Aiii, GlyR sIPSCs) and the isolated
glycinergic sIPSCs had a mean frequency of 5.7±0.4 events/sec, an average rise
time of 3.2±0.2 ms, a mean amplitude of 61.4±3.8 pA, and their average τdecay was
21.7±0.4 ms (Figure 4.2C). In the presence of both GABAR antagonists and
strychnine, all sIPSCs were eliminated (Figure 4.2Aiv, no sIPSCs), confirming that
the sIPSCs recorded in the presence of only GABA antagonists were isolated
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glycinergic sIPSCs. The average τdecay is significantly slower than either GlyRα1
or GlyRα3 (Figure 4.2B,D,E), which we determined in other studies (see Chapter
3) and were ~3.0 ms and ~9.0 ms, respectively. The slow τdecay of the GlyR sIPSCs
in WT ooDS RGCs suggests that they are mediated by GlyRα2 and/or GlyRα4
isoforms.
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Figure 4.2. WT ooDS RGC Glycinergic sIPSCs are Slow and are Likely Mediated
by GlyRα4. A) Raw traces of sIPSCs (red asterisks = GABAergic sIPSC, blue
asterisks = glycinergic sIPSC)(Ai), isolated GABAergic sIPSCs in the presence of
STRYCH (Aii), isolated glycinergic sIPSCs in the presence of PTX/TPMPA (Aiii),
and total block of sIPSCs in the presence of PTX/TPMPA/STRYCH (Aiv) in WT
ooDS RGCs. GABA sIPSCs were isolated in the presence of STRYCH, GlyR
sIPSCs were isolated in the presence of PTX/TPMPA, and all sIPSCs were
eliminated in the presence of PTX/TPMPA/STRYCH. B) Normalized average
glycinergic sIPSC of WT ooDS RGCs (black), ONα RGCs (grey), W3Glra1KD
(green) (See Chapter 3). C) WT ooDS RGC mean frequency (5.7±0.4
events/sec) (Ci), rise time (3.2±0.2 ms) (Cii), amplitude (61.4±3.8 pA) (Ciii), and
τdecay (22.3±0.6 ms) (Civ). D) Distribution of WT ooDS RGC glycinergic sIPSC
τdecay times. E) Cumulative distribution of glycinergic sIPSC τdecay times in WT
ooDS RGCs (black) and ONα RGCs (grey).

ooDS RGCs Express GlyRα4-Positive Puncta
As an independent measure of subunit specific expression, we assessed
GlyRα4 positive puncta on the ooDS RGC dendrites and compared the density to
an estimate of random puncta coincidence. The average ooDS GlyRα4-positive
puncta density was 0.15±0.02 puncta∙μm-1, which was significantly more than the
random GlyRα4-positive puncta density, which was 0.11±0.01 puncta∙μm-1 (Figure
4.3B,D p < 0.0004 (paired one-tailed T-test). When corrected for our estimate of
randomly associated GlyRα4-positive puncta, the corrected density of GlyRα4
puncta expression on ooDS RGCs was 0.04±0.01 puncta∙μm -1 (Figure 4.3D). This
corrected GlyRα4-positive puncta value suggest positive expression of GlyRα4 on
ooDS RGCs. GlyRα4 expression is absent in the Glra4-/- retina (Nobles et al.,
2012).
We also assessed GlyRα2 positive puncta on the ooDS RGC dendrites and
compared the density to an estimate of random puncta coincidence. The average
ooDS RGC GlyRα2-positive puncta density was 0.30±0.09 puncta∙μm-1, which was
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similar to the random GlyRα2-positive puncta density, which was 0.21±0.06
puncta∙μm-1 (Figure 4.3C,E, p > 0.05 (paired one-tailed T-test). When corrected
for our estimate of randomly associated GlyRα2-positive puncta, the corrected
density of GlyRα2 puncta expression on ooDS RGCs was 0.09±0.08 puncta∙μm -1
(Figure 4.3E). The similarity between the GlyRα2-positive puncta and chance
puncta coincidence suggests GlyRα2 expression is absent on ooDS RGCs.
GlyRα2 expression is absent in the Glra2-/- retina (Nobles et al., 2012).

Figure 4.3. ooDS RGCs Express GlyRα4 Puncta. (Images and data sourced from
(C. Zhang, 2015). A) Whole mounted En Face image of ooDS RGC filled with
neurobiotin (scale bar: 40μm). B) Wholemount image of ooDS RGC dendrites (Bi
– ON sublamina, Bii – OFF sublamina) stained for GlyRα4 expression (red)
(scale bar: 5μm). White arrows indicate representative co-localization of GlyRα4.
C) Wholemount image of ooDS RGC dendrites (Ci – ON sublamina, Cii – OFF
sublamina) stained for GlyRα2 expression (red) (scale bar: 5μm). White arrows
indicate representative co-localization of GlyRα2. D) Dendrites in WT ooDS
RGCs have significantly more GlyRα4 puncta density co-localization (μm-1) than
coincidence co-localization in the flipped (RAN) orientation (Wilcoxon Matchedpairs T-test, p value < 0.006). The corrected puncta density for GlyRα4 puncta on
ooDS RGCs is 0.04±0.01 μm-1(4 cells, 10 dendritic areas). E) Dendrites in WT
ooDS RGCs do not show significantly more GlyRα2 puncta density colocalization (μm-1) than coincidence co-localization in the flipped (RAN)
orientation (Wilcoxon Matched-pairs T-test, p value < 0.563). The corrected
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puncta density for GlyRα2 puncta on ooDS RGCs is 0.09±0.08 μm-1 (3 cells, 6
dendritic areas)
GlyRα2-Mediated Synaptic Inputs Remain in Glra4-/- ooDS RGCs
To test the hypothesis that the ooDS RGCs express GlyRα4, we recorded
glycinergic sIPSCs in Glra4-/- ooDS RGCs and found that the glycinergic sIPSC
frequency was 5.8±0.7 events/sec, which was similar to WT (Figure 4.4C; p >
0.05). In the presence of strychnine, all ooDS RGC glycinergic sIPSCs were
eliminated in the Glra4-/- indicating these were indeed GlyR-mediated. We
characterized the glycinergic sIPSCs in the Glra4-/- to determine what other GlyR
α subunit is expressed and mediates these slow glycinergic synaptic currents. The
Glra4-/- ooDS glycinergic sIPSCs had a mean rise time of 3.4±0.4 ms and were
similar to WT (Figure 4.4D, p > 0.05). The ooDS RGC glycinergic sIPSC mean
amplitude was 56.9±8.0 pA, which was similar to WT (Figure 4.4E, p > 0.05). The
glycinergic sIPSCs in the Glra4-/- ooDS RGCs had a mean τdecay of 23.5±1.8 ms,
which was also similar to WT (Figure 4.4F,G, p > 0.05). However, the τdecay
cumulative distribution of glycinergic sIPSCs of the Glra4-/- ooDS RGCs was
significantly different from WT and the curve was shifted to the right (Figure 4.4F,
Kolmogorov–Smirnov test p < 4.3e-5). Considering the GlyRα4 puncta expression
and the shift of the glycinergic sIPSC τdecay curve indicate GlyRα4 may be
expressed on ooDS RGCs, but the similar sIPSC frequency and kinetics led us to
hypothesize the majority of the glycinergic sIPSCs are mediated by GlyRα2.
Slow Glycinergic-Mediated sIPSCs Remain in the Glra2-/- ooDS RGCs
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We tested the hypothesis that GlyRα2 receptors mediate synaptic currents
in ooDS RGCs, and recorded from these cells in Glra2-/- retinas. Surprisingly, the
frequency of glycinergic sIPSCs in Glra2-/- ooDS RGCs was 6.3±0.4 events/sec
and was similar to both WT and Glra4-/- (Figure 4.4C; p > 0.05). In the presence of
strychnine, the glycinergic sIPSCs were eliminated, demonstrating they are GlyRmediated. The average rise time of the remaining glycinergic sIPSCs in the Glra2/-

ooDS RGCs was 3.5±0.2 ms and was similar to both the WT and Glra4-/- (Figure

4.4D, p > 0.05). The mean amplitude of the Glra2-/- ooDS RGC glycinergic sIPSCs
was 80.1±9.5 pA, and was similar to WT and Glra4-/- (Figure 4.4E, p > 0.05). The
average Glra4-/- ooDS RGC glycinergic sIPSC τdecay was 20.3±0.6 ms, which was
also similar to WT and Glra4-/- in the absence of GlyRα2 (Figure 4.4F,G, p > 0.05).
However, the cumulative glycinergic sIPSC τdecay curve differed significantly from
both WT and Glra4-/- (Figure 4.4F, Kolmogorov–Smirnov test, p < 0.02 (Glra2-/- vs.
WT) and p < 2.6e-04 (Glra2-/- vs. Glra4-/-). Considering the contention of eliminating
GlyRα2 or GlyRα4 and observing no loss of glycinergic sIPSC frequency in ooDS
RGCs, like we observe in other multi-subunit glycine receptor expression cells (see
Chapter 3), we examined the glycinergic sIPSCs in a double KO model (Glra4-//Glra2-/-).
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Figure 4.4. ooDS RGCs express both GlyRα2 and GlyRα4 A) Raw traces of
sIPSCs (Ai), GlyR sIPSCs isolated in the presence of PTX/TPMPA (Aii), and
eliminated sIPSCs in the presence of PTX/TPMPA/STRYCH (Aiii) in Glra2-/-,
Glra4-/- and Glra2-/-/Glra4-/- ooDS RGCs. B) Average glycinergic sIPSC trace of
Glra4-/- (red), Glra2-/- (Blue), and Glra2-/-/Glra4-/- (purple) ooDS RGCs C) Mean
frequency (events/sec) of glycinergic sIPSCs in ooDS RGCs: WT (5.7±0.4),
Glra4-/- (5.8±0.7),Glra2-/- (6.3±0.4), Glra2-/-/Glra4-/- (1.1±0.2). Glra2-/-/Glra4-/- GlyR
sIPSC frequency is significantly less than WT or single KOs (One-way Analysis
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of Variance, Bonferroni Post-Hoc test, **** p value < 0.0001). D) Average rise
times of ooDS RGC glycinergic sIPSCs in WT (3.2±0.2 ms), Glra4-/- (3.4±0.1 ms),
Glra2-/- (3.5±0.2 ms), and Glra2-/-/Glra4-/- (3.4±0.4 ms) are all similar (One-way
Analysis of Variance, Bonferroni Post-Hoc test, p value > 0.05). E) Average
amplitude of ooDS RGC glycinergic sIPSCs in: WT (61.4±3.8 pA), Glra4-/(56.1±9.0 pA), Glra2-/- (93.4±15.9 pA), and Glra2-/-/Glra4-/- (31.4±4.7 pA). Glra2-//Glra4-/- was significantly less than both WT and Glra2-/- (One-way Analysis of
Variance, Bonferroni Post-Hoc test, * p value < 0.05, *** p value < 0.001). F)
Cumulative distribution of GlyR sIPSC τdecay in ooDS RGCs: WT (black), Glra4-/(red), Glra2-/- (blue), Glra2-/-/Glra4-/- (purple). Glra2-/-/Glra4-/- GlyR sIPSC τdecay is
significantly faster than WT and both single KOs (Kolmogorov–Smirnov test). G)
The mean τdecay of ooDS RGC glycinergic sIPSCs was similar among: WT
(22.3±0.6 ms), Glra4-/- (23.5±1.8 ms) Glra2-/- (20.3±0.6 ms), and Glra2-/-/Glra4-/(11.8±1.5 ms) (One-way Analysis of Variance, Bonferroni Post-Hoc test, * p
value > 0.05).
Glra4-/-/Glra2-/- Eliminates 80% of the Glycine-Mediated Synaptic Inputs in ooDS
RGCs
To test the hypothesis that ooDS RGCs express both GlyRα4 and GlyRα2,
we recorded glycinergic sIPSCs in these cells using Glra4-/-/Glra2-/-/TRHR mouse
retinas. The Glra4-/-Glra2-/- ooDS RGC frequency of glycinergic sIPSCs was
1.1±0.2 events/sec, which was significantly less than WT, Glra4-/- and Glra2-/(Figure 4.4C, p < 0.0001). This significant reduction in glycinergic sIPSC frequency
indicates ooDS RGCs express both GlyRα2 and GlyRα4. However, some
glycinergic sIPSCs remain in the Glra4-/-Glra2-/- ooDS RGCs, and these were
eliminated in the presence of strychnine (Figure 4.4Aiii). We examined the
remaining glycinergic sIPSCs and found the average rise time of 3.4±0.4 ms was
similar to WT, Glra2-/-, and Glra4-/- (Figure 4.4D, p > 0.05). The average glycinergic
sIPSC amplitude of ooDS RGCs in the Glra4-/-/Glra2-/- was 31.4±4.7 pA, which was
significantly less than both WT and Glra2-/-, but similar to Glra4-/- (Figure 4.4E, p <
0.001). The mean τdecay of the remaining glycinergic sIPSCs in the Glra4-/-/Glra2-/110

ooDS RGCs was 11.8±1.5 ms and significantly less than WT, Glra4-/-, and Glra2-/(Figure 4.4G, p < 0.0001, One-way Analysis of Variance, Bonferroni Post-Hoc
test). Similarly, the cumulative glycinergic sIPSC τdecay curve differed significantly
from WT, Glra4-/-, and Glra2-/- (Figure 4.4F, Kolmogorov–Smirnov test, p < 8.08e84).

The characteristics of the remaining ooDS RGC glycinergic sIPSCs are most

similar to GlyRα3 currents that we recorded in F-mini RGCs in Glra2-/- retinas, and
in Glra1KD infected W3 RGCs (see chapter 3) (Table 4.2). Based on these
comparisons, we conclude that ooDS RGC glycinergic sIPSCs are primarily
mediated by GlyRα4 and GlyRα2, with ~20% missing arising from GlyRα3mediated.

Table 4.2. GlyRα3-Mediated sIPSC Currents.
RGC Type / Receptor / Model

Mean Rise Time (ms)

Mean Amplitude (pA)

F-mini / GlyRα3 /
W3 / GlyRα3 / Glra1KD
ooDS / GlyRα3? / Glra4-/-/Glra2-/-

2.0±0.1
2.5±0.4
3.4±0.4

22.4±3.0
26.9±3.1
31.4±4.7

Glra2-/-

Mean τdecay (ms)
7.8±0.4
10.1±1.0
11.8±1.5

rAAV-Mediated RNAi Reduces the GlyR-mediated sIPSC Frequency in rAAVGlra4-shRNA Infected ooDS RGCs
There are several reasons why the frequency of glycinergic sIPSCs in
Glra4-/- or Glra2-/- ooDS RGCs is similar to WT (Figure 4.4C). The frequency could
be maintained if the global absence of one or the other glycine receptor enhances
presynaptic glycine release onto the ooDS RGCs. There is also the possibility that
expression of each of these receptors could be upregulated in the absence of the
other, although we previously found no evidence for upregulation (Nobles et al.,
2012). The WT GlyR receptor could be a heteromer containing both α4 and α2
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subunits with a stoichiometry of (3β:1α4:1α2). In this case, when either GlyRα4 or
GlyRα2 expression was eliminated the remaining GlyR receptor would simply be
composed of the typically observed GlyR2α (3β:2α). There could be a fifth
unknown glycine receptor alpha subunit, although this is unlikely because only four
different α subunit genes are known from genetic screening.
To begin to distinguish among these possible scenarios, we eliminated
expression of each receptor subunit selectively in only RGCs (as opposed to a
global knockout) using an approach in which a retrogradely transported rAAV
shRNA knocks down GlyR expression (C. Zhang et al., 2014). We first targeted
double-labeled YPF positive ooDS RGCs with red nuclei in the rAAV-Glra4KDshRNA injected TRHR mice. In these infected cells expressing Glra4KD-shRNA,
the average frequency of glycinergic sIPSCs was 2.6±0.5 events/sec and was
significantly reduced compared to WT (Figure 4.5B; p < 0.0006). This glycinergic
sIPSC frequency represents a 55% reduction in glycinergic activity. Interestingly,
the average rise time became slower at 4.6±0.3 ms than both WT and Glra4-/(Figure 4.5C, p < 0.0001). The mean amplitude of glycinergic sIPSCs in the
Glra4KD-shRNA was 28.5±3.7 pA and was significantly lower than both WT and
Glra4-/- (Figure 4.5D, p < 0.0009). The average τdecay was 20.2±1.1 ms, which was
similar to WT and Glra4-/- (Figure 4.5F, p > 0.05). The cumulative distribution curve
of the glycinergic sIPSC τdecay of the Glra4KD-shRNA infected ooDS RGCs was
significantly different from both WT and Glra4-/- (Figure 4.5E, Kolmogorov–Smirnov
test, p < 5.9e-11). A reduced frequency and amplitude in the Glra4KD-shRNA
infected ooDS RGCs suggests the synapses express fewer GlyRs overall. The
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slow average τdecay suggests that the majority of the remaining glycinergic sIPSCs
are mediated by GlyRα2. To evaluate the effectiveness of rAAV-Glra4KD-shRNA,
we then recorded glycinergic sIPSCs from ooDS RGCs in rAAV-Glra4KD-shRNA in
the Glra2-/-/TRHR mouse model. We hypothesized the sIPSCs in this experiment
would be similar to the Glra4-/-/Glra2-/- and have some remaining sIPSCs with a
lower amplitude and a faster τdecay.

113

Figure 4.5. rAAV-Glra4KD-shRNA reduces the frequency of glycinergic sIPSCs in
ooDS RGCs. A) Raw traces of rAAV-Glra4KD infected ooDS RGC glycinergic
sIPSCs in cntl. bath (Ai), in the presence of PTX/TPMPA (Aii), and in
PTX/TPMPA/STRYCH (Aiii). B) The mean frequency (events/sec) of glycinergic
sIPSCs in ooDS RGCs was significantly lower in Glra4KD: WT (5.9±0.4), Glra4-/114

(5.8±0.7), Glra4KD (2.2±0.4) (p value < 0.0025 One-Way Analysis of Variance,
Bonferroni Post-Hoc test) C) Mean rise time (ms) of glycinergic sIPSCs in ooDS
RGCs in WT (3.2±0.4 ms), Glra4-/- (3.4±0.1 ms), and Glra4KD (4.6±0.3 ms).
Glra4KD is significantly higher than both WT and Glra4-/- (p value < 0.001 OneWay Analysis of Variance, Bonferroni Post-Hoc test). D) The mean amplitude of
ooDS RGC glycinergic sIPSCs was significantly less in Glra4KD: WT (61.4±3.8
pA), Glra4-/- (56.1±9.0 pA), and Glra4KD (28.1±4.3 pA) (p value < 0.0009 OneWay Analysis of Variance, Bonferroni Post-Hoc test). E) Cumulative distribution
of GlyR sIPSC τdecay in ooDS RGCs: WT (black), Glra4-/- (red), rAAV-Glra4KDshRNA (pink). Glra4KD τdecay distribution is no different than WT or Glra4-/(Kolmogorov–Smirnov test). F) Mean glycinergic sIPSC τdecay of WT, Glra4-/-, and
rAAV-Glra4KD-shRNA infected ooDS RGCs were all similar (p > 0.05, One-Way
Analysis of Variance, Bonferroni Post-Hoc test). G) Raw traces of Glra2-/- +
rAAV-Glra4KD infected ooDS RGC glycinergic sIPSCs in cntl. bath (Gi) and in
PTX/TPMPA (Gii), and in PTX/TPMPA/STRYCH (Giii). H) The mean frequency
(events/sec) of glycinergic sIPSCs in ooDS RGCs was similar between: Glra2-//Glra4-/- (1.2±0.2) and Glra2-/- + rAAV-Glra4KD infected ooDS RGCs (1.6±0.6) (p >
0.05, One-Way Analysis of Variance, Bonferroni Post-Hoc test). I) Mean Rise
time (ms) of glycinergic sIPSCs in ooDS RGCs in Glra2-/-/Glra4-/- (3.4±0.4 ms)
and Glra2-/- + rAAV-Glra4KD (4.3±0.4 ms), was similar (p > 0.05, One-Way
Analysis of Variance, Bonferroni Post-Hoc test). J) The mean amplitude of ooDS
RGC glycinergic sIPSCs was similar between: Glra2-/-/Glra4-/- (31.4±4.7 ms) and
Glra2-/- + rAAV-Glra4KD (31.0±10.1 ms) (p > 0.05, One-Way Analysis of Variance,
Bonferroni Post-Hoc test). K) Cumulative distribution of GlyR sIPSC τdecay in
ooDS RGCs: Glra2-/-/Glra4-/- (purple) and Glra2-/- + rAAV-Glra4KD (light blue). The
Glra2-/- + rAAV-Glra4KD glycinergic sIPSC τdecay is significantly shifted to the right
of Glra2-/-/Glra4-/- (Kolmogorov–Smirnov test). (L) The mean glycinergic sIPSC
τdecay of Glra2-/- + rAAV-Glra4KD (20.3±2.1 ms) is significantly slower than Glra2-//Glra4-/- (11.8±1.5 ms) (p < 0.05, One-Way Analysis of Variance, Bonferroni PostHoc test).
rAAV-Mediated RNAi in Glra2-/- ooDS RGCs Eliminates GlyRα4-Mediated
sIPSCs in rAAV-Glra4-shRNA Infected ooDS RGCs
In Glra2-/- ooDS RGCs infected with the Glra4KD-shRNA, the frequency of
glycinergic sIPSCs was 1.6±0.7 events/sec, which was similar to the frequency
recorded in Glra2-/-/Glra4-/- (Figure 5H, p > 0.05). The rise time of the infected ooDS
RGCs was 4.5±0.4 ms and similar to the rise time of the double knockout (Figure
5I, p > 0.05). The mean amplitude of the glycinergic sIPSCs in the Glra4KD-shRNA
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infected Glra2-/- ooDS RGCs was 33.7±11.3 pA and was also similar to the Glra2/-/Glra4-/-

model (Figure 5J, p > 0.05). Surprisingly, the glycinergic sIPSC τdecay

cumulative distribution of the Glra4KD-shRNA infected Glra2-/- ooDS RGCs was
significantly slower than the double knockout (Figure 5K, Kolmogorov–Smirnov
test, p < 6.8e-97). Correspondingly, the glycinergic sIPSC mean τdecay of the
Glra4KD-shRNA infected Glra2-/- ooDS RGCs was 21.7±1.8 ms and significantly
slower than the Glra4-/-/Glra2-/- (4.5L, p < 0.0007). The glycinergic sIPSC
frequency, rise time, and amplitude data suggest the Glra4KD-shRNA infected
Glra2-/- ooDS RGCs are identical to Glra4-/-/Glra2-/- ooDS RGCs. In contrast, the
glycinergic sIPSC τdecay of the Glra4KD-shRNA infected Glra2-/- ooDS RGCs was
significantly slower than Glra4-/-/Glra2-/- ooDS RGCs. The most likely explanation
is that a developmental difference occurs when these RGCs lack glycinergic
receptors from birth.
DISCUSSION
We demonstrated that WT ooDS RGCs receive synaptic glycinergic inputs
and that these inputs are mediated by postsynaptic GlyRs with slow decay kinetics.
Previous studies have shown that the α subunit of the GlyR is responsible for the
decay kinetics of the synaptic inputs, the sIPSCs. Furthermore, those studies
measured the sIPSC τdecay of GlyRα1 as ~3 ms, GlyRα3 as ~ 10 ms, GlyRα2 as
~27 ms, and GlyRα4 as ~53 ms at room temperature or 25°C (Majumdar et al.,
2007; Majumdar et al., 2009; Wassle et al., 2009). In our analysis of glycinergic
sIPSCs we estimated both GlyRα4 and GlyRα2 receptors to have a faster τdecay
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time than the reported results due to the fact that our recording was at the mouse
core body temperature of 36°C, which likely represents in vivo physiological GlyR
kinetics. We then tested our hypothesis that WT ooDS RGCs express either
GlyRα4 or GlyRα2 using immunohistochemistry and stained for GlyR α subunit
specific-mediated puncta. Our findings confirmed GlyRα4 is expressed on ooDS
RGCs, but were inconclusive of their expression of GlyRα2. Using Glra4-/- (global
knockout model) we recorded glycinergic sIPSCs in the ooDS RGCs and found
the frequency, rise time, amplitude, and mean τdecay similar to WT, and only the
sIPSC cumulative distribution of τdecay as an indication ooDS RGCs express
GlyRα4. We then recorded glycinergic sIPSCs in the Glra2-/- and also found them
to be similar to WT. Only when we recorded glycinergic sIPSCs from Glra4-/-/Glra2/-

did we see a significant reduction in sIPSC frequency, which demonstrated WT

ooDS RGCs express both GlyRα4 and GlyRα2. We also measured the remaining
sIPSCs and found their mean τdecay to be indicative of GlyRα3 ~10 ms. Further
investigation is needed to verify that GlyRα4 and GlyRα2 expression is
accompanied by the expression of GlyRα3 or another GlyR.
Intrigued by the similarity of the glycinergic sIPSC analysis results of the
single knockout model of ooDS RGC to the WT model, we recorded ooDS RGCs
infected with an rAAV-Glra4KD-shRNA and found the frequency of glycinergic
sIPSCs was reduced. Additionally, we tested the same Glra4KD-shRNA in Glra2-/to verify the effectiveness of the Glra4KD-shRNA. We found that the Glra2-/- + rAAVGlra4KD-shRNA infected ooDS RGCs had a similar frequency, amplitude, and rise
time as the Glra4-/-Glra2-/-. However, the mean τdecay and the cumulative
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distribution of the τdecay was significantly slower. This is likely due to the imperfect
efficiency of the Glra4KD-shRNA as observed in Chapter 3 and in (C. Zhang et al.,
2014). Our previous results from using an rAAV with shRNA to knockdown the
expression of a GlyR were effective but some glycinergic sIPSCs remained (C.
Zhang et al., 2014). It is likely some GlyRα4 expression remains the Glra2-/- +
Glra4KD-shRNA knockdown model, though low as mediated by the reduction in
sIPSC frequency, remaining sIPSCs mediated by this expression may cause the

τdecay kinetics to be more similar to WT.
Synapse-Specific Expression of GlyRα2 and GlyRα4
In RGCs that co-express two or more GlyRs (F-mini, LED, HD, UHD, and
J-RGC) the global knockout of a single GlyRα showed a reduction of glycinergic
sIPSC frequency and the remaining sIPSCs demonstrated their standalone
amplitude and kinetics (See Chapter 3). This result suggests different glycine
receptor subtypes are expressed at different synapses in the same cell since a
lower frequency of GlyR sIPSCs indicates less complete synaptic transmission due
to the entire loss of receptors in a single synapse. However, evaluations of
glycinergic sIPSCs in Glra2-/- or Glra4-/- in ooDS RGCs showed no change
frequency or amplitude, which suggested two possibilities: 1) WT ooDS RGCs coexpress GlyRα4 and GlyRα2 in different synapses, and global loss of one of these
glycine receptors alters inhibition to their presynaptic amacrine cell. This change
increases glycine release from the amacrine cells and a concomitant increase in
GlyR sIPSC frequency in the ooDS RGCs, effectively masking the fewer number
of GlyR synapses. 2) WT ooDS RGCs also co-express GlyRα4 and GlyRα2 in this
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scenario, however, the loss of one glycine receptor subtype is compensated by the
expression of the remaining glycine receptor expressed in the cell. Furthermore, it
is conceivable the trafficking mechanisms for the two GlyRs could be the same,
and traffic GlyRα2 or GlyRα4 interchangeably because these two GlyRs share a
91% homology (Matzenbach et al., 1994).
Scenario one is unlikely because we demonstrated drastic loss of
glycinergic sIPSC activity in the Glra4-/-/Glra2-/- ooDS RGCs. Splice variants of the
GlyRα2 subunit have been found in the brain and spinal cord, making this scenario
important to consider in future investigations (Miller et al., 2004; Oertel, Villmann,
Kettenmann, Kirchhoff, & Becker, 2007). In the second scenario, the loss of a
single glycine receptor could affect the downstream release properties of glycine
vesicles onto ooDS RGCs, and mask the loss of GlyR expression by overreleasing glycine into synapses with the remaining GlyR. However, GlyRα2,
GlyRα3, and GlyRα1 are densely expressed throughout the IPL, yet GlyRα4 is
expressed only in the ON choline Acetyltransferase band in the IPL. (Buldyrev,
Puthussery, & Taylor, 2012; Demb & Singer, 2012; Eggers & Lukasiewicz, 2006a;
S. C. Lee et al., 2015; Manookin et al., 2008; Wassle et al., 2009; Weiss et al.,
2008). As a result, to date, GlyRα4 has only been found expressed in the ON SAC
cells, which are synaptically connected to ooDS RGCs, but do not release glycine
(S. C. Lee et al., 2015; Menger, Pow, & Wassle, 1998; Pow & Hendrickson, 1999).
It is unlikely that both single knockouts would similarly affect the downstream ACmediated glycine release onto ooDS RGCs because of the differential expression
of GlyRα2 and GlyRα4. Nevertheless, the ON SACs may express both GlyRα2
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and GlyRα4 (see Chapter 3), and the global loss of either GlyR may affect a serial
inhibition connection, which influences glycine release onto the ooDS RGCs. And,
GlyRα4 and GlyRα2 are kinetically similar. This scenario where glycine release is
upregulated in the single knockout of either GlyRα4 or GlyRα2 is more likely to
occur than the existence of a splice variant. However, the feasibility of both single
KOs affecting glycine release onto the ooDS RGCs in a similar manner is not
substantial.
In the third scenario, enough of the remaining GlyR mRNA in a single global
knockout of another GlyR, is already present and it is translated and trafficked to
the synapses, which would normally express the knocked out GlyR i.e.
compensation for the loss of the knocked out GlyR. Or, compensation could occur
via a more complex mechanism where there is gene overexpression of the
remaining GlyR. We did successfully demonstrate this scenario is unlikely in our
experiments using rAAV-Glra4KD-shRNA. In this experiment, the glycinergic
sIPSC frequency was significantly reduced in rAAV-Glra4KD-shRNA infected WT
ooDS RGCs. Also, the average GlyR turnover rate is about 20 hours, while in our
rAAV injection experiments the rAAV-Glra4KD-shRNA was in the retina for up to a
week before recording (Chow, Zuchowski, & Fetcho, 2017). However, this scenario
is still the most feasible explanation for our findings because our experiments did
not account for the upregulation or overexpression of the remaining GlyR in the
single KO models that could have occurred during development. Our experiments
should be recapitulated and account for the loss of a GlyR and the possible
compensation of that loss during development. Furthermore, one could potentially
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measure the rate of GlyR expression during development in a single KO model
using qPCR.
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CHAPTER V
DISCUSSION
I. GENERAL DISCUSSION
Studying the brain as a vision scientist gives one exposure to almost every
facet of biomedical research. Researchers from almost every discipline can find a
way to investigate the visual system. By using the tried and true methods of
electrophysiology and immunohistochemistry, I successfully managed to add to
the vast and quickly growing body of knowledge concerning vision. Though these
methods continue to be the gold standard, vision research is expanding into realms
likely never fathomed by the great vision scientists such as Barlow and Hill, EnrothCugell and Kuffler. The rapid development of technology and the mixing of
disciplines has given vision researchers tools to parse out circuits, discover new
cell types, and model the visual system for artificial intelligence. This field will likely
continue to expand and will be fascinating to watch from the perspective of a
scientist.
CHAPTER III Summary
We successfully identified much of the GlyRα subunit specific expression in
a subset of RGCs, which together make up about 50% of the roughly 40,000 retinal
ganglion cells found in a mouse retina. Collectively, these cells differentially
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express all four different glycine receptor subtypes in the IPL. The α RGCs express
GlyRα1, the LED, HD, and UHD RGCs express both GlyR both GlyRα3 and
GlyRα1, the F-mini RGCs express both GlyRα2 and GlyRα3, the J-RGCs express
GlyRα2, and the ON SACs likely express both GlyRα4 and GlyRα2. This is a
comprehensive list of identified RGCs that collectively express each of the four
GlyRα subunits. This list can now be exploited to investigate the individual roles of
the different GlyRs within the retina. Furthermore, we developed an assay to
investigate GlyR expression via a global knockout approach. This approach can
be used to study other RGCs of interest and discover their GlyR subunit specific
expression. Future research of retinal inhibitory circuits should evaluate the role of
glycinergic inhibition at the level of the specific GlyR subunit as opposed to an allor-none approach with disregard to subtle differences that avoid new discoveries.
Though our knockout approach was sufficient in the investigation of some
of the RGC types, we employed a more powerful tool, the use of two different rAAV
delivered shRNAs to knock down the expression of Glra1 and Glra4. The
knockdown experiments are superior to the global knock out experiments for many
reasons: 1) Only glycine receptors expressed on infected RGCs are knocked
down. Thus, with synapses and all glycine receptors of the upper circuitry intact,
measurable changes are not masked or amplified by the loss of glycine receptors
in other retinal cells. 2) In addition to studying glycine receptor function on retinal
ganglion cells, knocking down glycine receptor expression also isolates the
GABAergic receptors allowing for the study of their function. 3) rAAV delivered
shRNAs allow for precise temporal control of the target gene so the injected animal
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can mature into adulthood with all inhibitory circuitry and the synapses intact. Then,
only the glycine receptors are knocked down, potentially preserving glycine release
properties and the glycinergic synapses in amacrine cells and bipolar cells.
CHAPTER IV Summary
While identifying the expression or co-expression of glycine receptors on
specific ganglion cells, a pattern emerged where the loss of a single glycine
receptor always resulted in a decrease of GlyR activity. We observed this
phenomenon by measuring the glycinergic sIPSC frequency in the ONα, ON T,
OFFα, OFFδ, UHD, LED, HD1, HD2, F-mini, J-RGCs, and the ON SACs. However,
when measuring the frequency of glycinergic sIPSCs in the ooDS RGCs, the loss
of a single receptor (either GlyRα2 or GlyRα4), did not result in a decrease of GlyR
activity. It was not until the double knockout of both co-expressed GlyRα2 and
GlyRα4 did a significant decrease in glycinergic sIPSC activity occur. In both single
knockout examples, Glra2-/- or Glra4-/-, the remaining GlyR sIPSC frequency was
unchanged from WT. The possible mechanisms which explain this abnormality
are:
1) The presence of a splice variant of one of the GlyRα subunits, which have
been found for GlyRα2 and the GlyRβ subunit (Miller et al., 2004; Oertel et al.,
2007). However, the splice variants of GlyRα2 are kinetically identical and their
presence in the retina would be undetectable using our electrophysiological assay
(Miller et al., 2004).
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2) Another possibility is that both GlyRα2 and GlyRα4 are co-expressed in
the ooDS RGCs. The global knockout of a single GlyRα subunit would result in an
increase of the glycine release from amacrine cells onto the ooDS RGCs. The
increase in glycine release would compensate for the loss of the single coexpressed GlyR and the typical observed decrease in frequency would effectively
be masked. Since, we observed identical results in both Glra2-/- and Glra4-/-,
compensation of glycine release from presynaptic ACs would likely be similar.
However, we know the expression of GlyRα2 and GlyRα4 is differential.
Furthermore, there is evidence of GlyRα2 expression on narrow-field glycinergic
amacrine cells. Yet, the only AC known to express GlyRα4 is the wide-field
starburst AC; which certainly connects synaptically with ooDS RGCs, but it does
not release glycine. However, the ON SAC could be involved in a serial inhibition
circuit with a glycinergic amacrine that releases glycine into the inhibitory synapses
of the ooDS RGCs. If the ON SAC does express both GlyRα4 and GlyRα2, then
altered GABA release in the proposed serial circuit resulting in either Glra4-/- and
Glra2-/- could culminate in similar glycinergic sIPSC frequency.
3) The final scenario is also possible if ooDS RGCs co-express both GlyRα2
and GlyRα4. In a congenital knockout of a single GlyRα subunit, the remaining
normally co-expressed GlyR expression is increased to compensate for the loss
of the knocked out GlyR. In addition to the previous idea is that remaining
endogenous expression was already high enough to compensate for the loss of
the co-expressed GlyR. We observed no compensation in the knockdown model
and furthermore, compensation of any GlyR in a single GlyR KO has not been
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observed (Nobles et al., 2012). However, our knockdown model does not take into
account the possibility of compensation of the remaining GlyR in the single GlyR
KO during development. Further study is needed to verify this more plausible
scenario including both a developmental study, and the measurement of mRNA
expression of GlyRs in ooDS RGCs during development in WT and single KO
models, and after the infection of an rAAV-Glra4KD-shRNA.
After we identified the GlyR co-expression of GlyRα2 and GlyRα4 on ooDS
RGCs, we set out to identify the mechanism in which these cells successfully
maintain their glycinergic sIPSC frequency after a single GlyR knockout. We
employed the rAAV delivered shRNA method to knock down the expression of
GlyRα4 and found glycinergic sIPSC frequency indeed decreased after the loss of
the GlyRα4, yet some glycinergic sIPSC activity remained, presumably mediated
by GlyRα2. This result suggests that any method of glycinergic sIPSC activity
compensation occurs during or before synapse development, or is dependent on
the loss of GlyRα4 on presynaptic amacrine cells.
II. FURTHER DIRECTIONS
GlyR function is dependent on the release properties of the presynaptic
amacrine cells. Using known labeled presynaptic amacrine cell and post-synaptic
ganglion cell pairs could aptly reveal glycine receptor function. An example would
be to explore the glycine release properties of the Vglut3 amacrine cell onto the
W3B cells (specifically LED cells as opposed to the other cells labeled in the W3B
line (HD1, HD2, or UHD cells) (T. Kim et al., 2015). The W3 cells express both
GlyRα1 and GlyRα3 in different synapses. The Vglut3 amacrine cell may release
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glycine onto only one receptor subtype. It is also possible that the co-expression
of glycine receptors enables coordinated inhibitory kinetics, which would be
impossible from single GlyR expression. I.e., the cooperation between coexpressed GlyRα1 and GlyRα3 on LED cells would be different from the individual
expression of GlyRα1 or GlyRα3. If these co-expressing GlyRs have a harmonious
function, then the tuning of the inhibitory signal is more acute than what can be
created by the four individual receptors subtypes alone.
This idea of harmonious function among two co-expressed GlyRs has not
been observed. Instead, the need for the variety of different GlyR decay kinetics is
observed in two different types of cells of the VCN. The bushy cells and the T
stellate cells of the VCN express different subunit specific GlyRs, which individually
mediate the temporal inhibition differently (slow kinetic GlyRs increase the spike
threshold improving spike precision in bushy cells while fast kinetic GlyRs mediate
rapid inhibition that preserves the spike threshold and eliminates poorly timed
spikes improving spike timing in T stellate cells (Xie & Manis, 2013). Given the
variety of visual response properties of the forty different retinal ganglion cell types,
it should not be surprising that there is a need for four different subunit specific
GlyRs. The different GlyRs likely play unique roles in modulating the different
excitatory input into each different RGC type. For instance, the kinetically slow
GlyRα2 and GlyRα4 likely improve spike precision in the ooDS, ON SAC and JRGC cells in a similar manner to the bushy cells of the VCN. Then, kinetically faster
GlyRs expressed on the W3 cells may match their inhibitory input with fast
excitatory input, like the T stellate cells of the VCN, to not interfere with the
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membrane potential, but instead improve excitatory spike timing output and inhibit
poorly timed spikes.
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